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ABSTRACT 
Purpose of the Project: 
Meningitis remains serious clinical problem in developing 
countries.Delayed diagnosis and treatment remit in significant morbidity 
and mortality. Meningitis represents a serious disease that is associated 
with significant morbidity and mortality. Outcomes of bacterial 
meningitis have remained stable since the advent of antibiotics, with the 
case fatality being as high as 25%. Long-term sequelae such as hearing 
loss, palsies and personality changes affect approximately 40% of 
survivors. Early antibiotic therapy is crucial for optimizing the outcome 
of bacterial meningitis. Therefore, it is important to distinguish bacterial 
meningitis from aseptic meningitis during the acute phase of the disease, 
when clinical symptoms are often similar as this could help to avoid 
complications and to limit unnecessary antibiotic use .However, a 
sensitive laboratory test that is easy to perform is still required, so that all 
patients with bacterial meningitis can be identified reliably on admission. 
Background: 
Signs and symptoms, results of routineCSF analysis and 
radiological findings are inadequate in making a definitive diagnosis. 
Gram’s stain and AFB stain of CSF are rapid technique for detection of 
organism but lack sensitivity.Similarly CSF culture is another method of 
diagnosis but it is time consuming.PCR is highly specific and sensitive 
but costly and not widely available. In the view of these limitations, 
determination of CSF CORTISOL levels in differentiating bacterial from 
nonbacterial meningitis is useful as a diagnostic and valuable marker.  
Aims and Objectives:  
The study was aimed to evaluate the utility of CSF Cortisol in 
differentiating Bacterial from Non Bacterial meningitis. 
Data Collection and the Source: 
For all patients admitted in CMCH, who fulfilled the inclusion and 
exclusion criteria CSF cortisol estimation is done and routine CSF 
analysis for diagnosing meningitis. 10 normal control subjects with no 
neurological illness undergoing spinal anesthesia are included. Control 
CSF cortisol estimation is done. Informed consent was taken from all 
patients. 
Methods: 
  A cross sectional observational study was done in forty of 
suspected meningitis of varied etiologies and 10 control subjects without 
any pre-existing neurological disorders who have undergone lumbar 
punctureduring spinal anesthesia were included in the study. All the 
patients were thoroughly examined clinically by preformed proforma and 
investigated. 
 
Case definition:  
Patients with clinical suspicion of meningitis presenting with fever, 
vomiting, altered sensorium, and nuchal rigidity. 
Results:  
Mean cerebrospinal fluid cortisol activity was 13.06µg/dl,4.44µg/dl, 
2.29µg/dl and 1.05µg/dl in neutrophilic meningitis, lymphocytic 
meningitis, aseptic meningitis and controls respectively.  Mean CSF-
Cortisol level in neutrophilic meningitis was significantly higher as 
compared to other groups. 
Conclusion:  
CORTISOL activity in CSF is a rapid, relatively inexpensive 
and simple procedure, and can be of great value in the early 
differentiation of neutrophilic, lymphocytic and aseptic meningitis, thus 
helping in earlier institution of appropriate treatment and thereby 
decreasing morality and complications. 
Key words: CSF-Cerebrospinal fluid, Cortisol, Neutrophilic meningitis, 
lymphocytic meningitis and aseptic meningitis. 
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INTRODUCTION 
Meningitis is defined as inflammation of the leptomeninges and 
underlying subarachnoid cerebrospinal fluid (CSF). Meningitis is the 
inflammation of the protective membranes covering the central nervous 
system, known collectively as the meninges
1
. 
Meningitis is a turning out to be major problem of the world. 
Meningitis is the result of various etiologies factors can be categorized 
into pyogenic, tubercular or aseptic meningitis. 
Of these, bacterial meningitis is a common infectious disease of the 
CNS in developing countries like India, and also a major global health 
problem even in the developed countries of the world. It represents a 
serious disease associated with significant morbidity and mortality
2
. 
Furthermore, long-term sequelae such as hearing loss, cranial nerve 
palsies and personally changes affect approximately 40% of survivors
3
. 
Pneumococcal, Haemophilus influenza and meningococcal 
meningitis have a worldwide distribution, mainly seen m young age 
groups. Since the introduction of vaccine against these agents, incidence 
of meningitis has dramatically reduced in developed countries. But 
incidence remains the same in the developing world. 
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Signs and symptoms, results of routine CSF analysis and 
radiological fading are often inadequate m ticking a definitive diagnosis. 
Clearly a prompt laboratory test is required to differentiate these 
various types of meningitis Gram's stain and AFB stain of CSF are rapid 
methods of detection of organism, but lack sensitivity. 
Similarly, culture of CSF is another method of diagnosis but it is 
time consuming. 
PCR test is a highly sensitive and specific test but is very coaly and 
not widely available. 
Therefore, for differentiation among various types of meningitis, a 
reliable and cost effective test should be available. 
In view of all these limitations, determination of CSF-CORTISOL 
activity may be a diagnostic and valuable marker in differentiating 
bacterial from nonbacterial meningitis
4
. 
Detection of high level of CSF cortisol has shown promising 
results in the diagnosis Bacterial meningitis. 
The main purpose of this study is to evaluate utility of CSF 
CORTISOL in differentiating bacterial from nonbacterial meningitis. 
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Aims of the Study 
 
 
1. To evaluate the utility of CSF Cortisol levels in differentiating 
Bacterial and Non-Bacterial meningitis. 
2. To study CSF Cortisol levels in Bacterial (neutrophilic) and Non-
Bacterial (lymphocytic and aseptic) meningitis. 
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REVIEW OF LITERATURE 
Review of history: 
CSF was discovered by DomenicoLentango in 1774 and Carnig 
was the first to puncture the subarachnoid space in living person. 
Pepavoine described in 1830 the anatomical nature of tuberculous 
meningitis and called it as “ArachnoiditisTuberculosa'’.  
Gren PH coined the term tuberculous meningitis in 1836. 
Robert Koch discovered the acid fast bacilli on 24th March 1882. 
Valdmer Kernig described the Kernig’s sign in 1884. 
HenrichQuincke in 1891 devised plain needle for lumbar puncture, 
thus greatly facilitating the study of CSF for diagnostic purposes. 
Brudzinski in 1909 described neck sign consisting of passive 
flexion of neck resulting in flexion of knee and hips. The Brudzinski's 
sign is more sensitive if neck flexion is attempted with patient in a sitting 
position with legs extended parallel to the floor. In his original paper he 
also described leg sign. 
Mastertzed in 1912 reported the chemical composition of CSF in 
meningitis. 
In 2006, Sunit C Singhi et al suggested Serum cortisol could be 
useful in assessment of acute bacterial meningitis
5
. Similarly, CSF 
cortisol was adopted for diagnosis of bacterial meningitis. 
5 
 
Anatomy and Physiology 
The human brain and spinal cord is covered by protective 
coverings called meninges. They are three in number and are named as 
the pia mater (the inner most), the arachnoid mater (the intermediate 
layer), and the Dura mater (the outer most layers). 
Dura mater 
It is also called as pachymenix. The two layers of cranial Dura are 
outer endosteal (periosteal layer) layer and inner meningeal layer. 
The periosteal layer of Dura is covering the internal surface of the 
cranial bones. This Dural layer is continuous with the periosteum of the 
cranium around the foramina margins.  
The meningeal layer (Dura mater proper) is a dense and strong 
membrane around the brain. The dura proper continuous below as dural 
covering of the spinal cord. This layer forms sheaths for the exiting 
cranial nerves passing through the skull foramina. 
The meningeal layer has four septa inside skull that divide the 
cranial cavity into multiple spaces that communicate freely. The function 
of these septa is to prevent the brain displacement due to acceleration and 
deceleration forces, during head movement. 
6 
 
Reflections of dura: 
The falx cerebri is the largest in fold of dura in the longitudinal 
cerebral fissure separates the two cerebral hemispheres. It merges in 
posterior aspect with the cerebellar tentorium.  
The cerebellar tentorium (tentorium cerebelli) is a second largest 
fold of Dura mater that overlies the posterior cranial fossa. It separates 
the occipital lobes of cerebral hemispheres from cerebellum. It also 
supports the occipital lobes.  
The falxcerebri (cerebellar falx) attaches to cerebellar tentorium 
and there by supports it. The falx cerebelli is a vertical dura and is 
attached to inferior part of cerebellar tentorium. The cerebellar falx 
partially separates the cerebellar hemispheres.  
The sellar diaphragm (diaphragmasellae) is a smallest in fold of 
dura mater and forms partial roof over hypophysial fossa. 
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This figure shows dural covering and subarachnoid space 
(purple) around the brain, are continuous with that around the 
spinal cord: 
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This figure shows two layers of dura mater separate to form 
dural venous sinuses: 
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The dura is innervated by meningeal branches of trigeminal nerve. 
Other branches are from vagus, C1.C2, C3 nerves and branches from 
hypoglossal nerve. There are many sensory endings along each side of the 
superior sagittal sinus and in the cerebellar tentorium which are sensitive 
to stretching. Pain arising from the dura is generally referred, perceived 
as a headache (in cutaneous or mucosal regions supplied by the involved 
cervical nerve). Stimulation of sensory nerve endings above cerebellar 
tentorium causes referred pain over the same side of head. Sensory nerve 
endings below the level of the tentorium cerebelli produces referred pain 
to the back of the neck and scalp along greater occipital nerve 
distribution.  
The vasculature of dura is from the internal carotid arteries, middle 
meningeal artery branch from maxillary artery, occipital, and small 
branches from vertebral arteries. The most important branch is the middle 
meningeal artery. Because it is more prone for damage related to injuries 
of head. 
Arachnoid Mater: 
The arachnoid layer is delicate and impermeable covering over the 
brain. It lays in between two other coverings of brain namely pia mater 
and dura mater. The subdural space between arachnoid and dura is filled 
with a small amount of fluid. The subarachnoid space is between pia 
mater and arachnoid mater which contains with cerebrospinal fluid. 
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The subarachnoid cisterna is the wide separations between pia 
mater and arachnoid mater at the point of arachnoid mater bridging over 
sulci. There are two cisterna one is cerebellomedullaris (between 
cerebellum and fourth ventricle) and other cisterna interpeduncularis        
(between cerebellar peduncles). These cisternae are freely connected to 
one another and with rest of the subarachnoid space.  
In some areas the arachnoid mater enters into the venous sinuses 
forming arachnoid villi which are more around superior sagittal sinus. 
These arachnoid villi aggregate in some areas to form arachnoid 
granulations. The main function of arachnoid villi is to drain the 
cerebrospinal fluid into blood vessels. 
There are numerous fibrous strands in subarachnoid space that 
connect pia mater and arachnoid mater. The cerebral vessels and nerves 
lie in the space, in case of optic nerve it envelops till its entry into eye 
ball and finally merges with sclera.  
The choroid plexuses are the protrusions of arterial tufts into the 
ventricle which produce CSF. They are located in 2 lateral ventricles, 
third and fourth ventricle. The CSF exits the fourth ventricle through the 
foramina in its roof into the subarachnoid space. Here it baths the surface 
of brain and spinal cord below and finally diffuses into blood vessels via 
arachnoid villi.  
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Pia Mater: 
The pia mater is a thinner membrane that is highly vascularised by 
fine blood vessels. It is adherent to surface of brain and follows the 
contour of brain (including gyri and sulci) and responsible for the shiny 
appearance of brain. It forms pial coat and a periarterial space around 
arteries penetrating the cerebral cortex, and epineurium around nerves. 
The pia mater also forms the telachoroidea at the roof of third and fourth 
ventricles, and choroid plexus along with ependymal tissue which 
protrudes into the ventricles. 
Choroid plexus 
These are present in ventricular cavities and are lined by 
ependymal. They are protrusions of tuft of arteries lined by pia mater in 
the ventricles. They are present in all ventricles largest tuft in lateral 
ventricle. They produce cerebrospinal fluid. The epithelium of the 
choroid plexus represents a barrier between the blood and the CSF, the 
blood-CSF barrier. Thus, many substances that can leave the capillaries 
of the choroid plexus cannot enter the CSF. 
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Physiology of cerebrospinal fluid (CSF): 
It is called the lymph of brain by Claudebernard. The brain and 
spinal cord is bathed by CSF in subarachnoid space. The Lipid-soluble 
substances (CO2 and O2) and water, freely cross the blood-brain barrier 
and equilibrate between blood and CSF. Protein and cholesterol are 
excluded from the CSF because of their large molecular size. 
Circulation and Drainage of the Cerebrospinal Fluid 
About one-half liter of CSF is produced each day, still the net 
volume of CSF in the ventricles and the subarachnoid space is 130-140 
ml (approximately 25ml is in the ventricles) [7]. In addition, 
approximately 75 ml surrounds the spinal cord. Thus, the total amount is 
renewed several times a day .The CSF is produced in the lateral ventricles 
which enters into the third ventricle through the interventricular foramen 
of Monro. From there CSF flows to fourth ventricle through the narrow 
cerebral aqueduct. More CSF formed by choroid plexus is added in the 
third and fourth ventricles. The fluid enters the subarachnoid space (more 
specifically, the cisterna magna) through openings in the roof of the 
fourth ventricle. The openings are named as the foramen of Magendie 
(one in the midline posteriorly) and the lateral recesses or foramina of 
Luschka (two laterally in roof of fourth ventricle). The CSF then baths 
over the entire cerebral surface and spinal cord till second sacral vertebra. 
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 The velocity with which CSF flows is not even, however, as shown 
by following the spread of injected substances. The direction of CSF from 
the base of the cerebrum is upwards along the lateral surface of cerebral 
hemispheres towards midline where most of the fluid diffuses into venous 
sinuses. This happens by way of small evaginations of the arachnoid—
arachnoidvilli—into the venous sinuses. 
The diffusion of CSF from subarachnoid space to the venous sinuses is 
probably caused by a difference in hydrostatic pressure, which is at  
higher level  in the subarachnoid space (about 15 cm H2O) than in the 
venous sinuses (7-8 cm H2O). Some of the CSF is drained along other 
routes, such as lymphatic vessels in cranial and spinal nerves. 
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Circulation and Drainage of the Cerebrospinal Fluid 
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Composition of Cerebrospinal Fluid 
The concentration of sodium, potassium, and several other ions is 
about the same in the CSF as in the blood (there are some minor 
differences, however). The concentration of glucose is about two-thirds 
of that in the blood. A major difference concerns proteins: there is 
normally very little protein in the CSF (less than 0.5% of the plasma 
protein concentration). Water and soluble substances are freely 
exchangeable between the CSF and the interstitial fluid of the nervous 
tissue because the ependyma is freely permeable to water and even small 
protein molecules. It is not surprising, therefore, that many 
neurotransmitters, peptides, and other neuroactive substances can be 
found in the CSF, and their presence there does not by itself signify a 
functional role. Some substances, however—notably hormones 
synthesized in the anterior pituitary—are apparently actively secreted into 
the CSF, not simply accepted by passive diffusion. There is evidence that 
some other substances use the CSF as a means to reach specific receptors 
close to the ventricles. We mentioned at the beginning of this chapter 
that, because the brain almost floats in it, the CSF has important 
protective functions. This buoyancy reduces the weight of the brain to 
about 50 g, which means less traction on vessels and nerves connected 
cerebrum and spinal cord. Furthermore, the effect of blows to the head on 
16 
 
the brain is dampened because water has to be pressed aside before the 
brain hits its hard surroundings (the skull). Another possible functional 
role of the CSF can be deduced from the fact, mentioned above, that 
water and solutes pass freely between it and the extracellular fluid 
(interstitium) of the nervous tissue. This means that the accumulation of 
substances in the nervous tissue (such as potassium ions during prolonged 
periods of intense neuronal activity) may be minimized by diffusion into 
the CSF. This would be of significance, however, only for neurons that 
are fairly close to the ventricles. The diffusion of molecules in the 
labyrinth like brain interstitium is much slower than in free water. Thus, 
after injecting representative substances in the brain, the concentration is 
reduced by 90% some 1 to 3 mm away from the injection site. 
Regardless of the normal functions of substances in the CSF, 
examination of the CSF composition gives valuable information of the 
extracellular fluid of the brain. This fluid compartment is difficult to 
examine directly, but since the ependyma is freely permeable, one can 
safely assume that the composition of the CSF matches fairly well the 
environment of the neurons. 
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Comparison of Cerebrospinal Fluid (CSF) and Blood Concentrations 
 
CSF &thkap; Blood CSF < Blood CSF > Blood 
Na
+
 K
+
 Mg
2+
 
Cl
-
 Ca
2+
 Creatinine 
HCO3
-
 Glucose 
 
Osmolarity Cholesterol
*
 
 
Protein
*
 
* 
Negligible concentration in CSF. 
Normal  CSF  constituents: 
Protein- 
             Ventricular- 5-15 mg/dl 
             Lumbar- 15-25 mg/dl 
   Cisternal- 14-45mg/dl 
Glucose- 44-100 mg/dl 
Chloride- 725-750 mg/dl 
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Phosphorus- 7.31(at arterial PH of 7.41) 
Cells present in CSF- 0-5 cells mm
3
 mainly lymphocytes 
Enzymes present in CSF- LDH, AST and CPK. 
Normal pressure of CSF- 100-200 is cm of H2O. 
Functions of CSF 
1) Provides buoyancy which reduces the weight of the brain to about 50 
g, which means less traction on vessels and nerves connected to the 
central nervous system. 
2) It regulates the intracranial pressure. 
3) Supports venous sinuses. 
4) Acts as secondary pathway in hormonal transport and distribution. 
5) Maintenance of homeostasis and removal of waste products. 
6) Acts as buffer and maintains pH, there by regulates respiration. 
7) Plays an important role in nutrition and metabolism in CNS. 
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Types of meningitis:- 
Meningitis can be categorized according to CSF cytochemical 
picture as, neutrophilic meningitis, lymphocytic meningitis, and aseptic 
meningitis. 
Neutrophilic meningitis: 
                 The most common cause is bacterial infection. Other rare 
causes are fungal infections, nocardia infection, actinomyces infection 
etc.  
Bacterial meningitis: 
  Acute bacterial infection of meninges causes a clinical picture of 
acute meningitis. It is often referred as bacterial meningitis or septic 
meningitis or purulent meningitis. Most often meninges, subarachnoid 
space and brain parenchyma are all involved in inflammatory reaction 
causing meningoencephalitis. 
Currently most common organisms responsible for community 
acquired bacterial meningitis are streptococcus pneumonia, 
meningococcus, Hemophilus influenza, group B Streptococcus and 
Listeria monocytogenes
[1]
. Neisseria meningitides and Streptococcus 
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pneumoniae are the most common pathogens responsible for meningitis 
in normal individuals (without immune deficiency). 
 Streptococcus pneumoniae is the most common pathogen 
responsible for meningitis in adults above 20 years. The predisposing 
conditions are pneumonia due pneumococcus, sinusitis, mastoiditis, otitis 
media, cochlear implants, diabetes mellitus, post splenectomy.
[2]
 
Neisseria meningitides is most common in adolescent and young 
adults (2- 20 years). The bacteria are usually recovered from blood or a 
cutaneous lesion before meningitis starts, indicating that spread to the 
CNS is hematogenous.  Occasionally it may gain access directly from the 
nasopharynx through cribriform plate. Found in individuals with 
complement deficiency including properdin
[3].
 
In infants and children most common organisms are pneumococcus, 
Neisseria meningitides and Hemophilus influenzae type b. 
In infancy most common pathogens are Group B Streptococcus, 
Escherichia coli, Listeria monocytogenes. L.Monocytogenes is frequently 
reported in meningitis above 50 years, especially adults with chronic 
diseases (e.g. renal disease with dialysis, malignancy, connective tissue 
disorders). 
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 Staphylococci (S. aureus and S. epidermidis) and gram-negative 
bacilli are common pathogens in patients following a neurosurgical 
procedure. Sometimes it is a complication of cavernous sinus thrombosis, 
subdural or epidural abscess. 
 Recurrent Bacterial Meningitis signal a host defect, either in local 
anatomy or in antibacterial and immunologic defenses. 
1. Defects in local anatomy, for example: 
• Head trauma causing CSF rhinorrhoea due basilar skull fracture. 
• Fracture to temporal bone with access of microorganisms from the ear  
• In situ shunts (ventriculovenous shunting) for treatment of              
 hydrocephalus. 
2. General causes (defective immunologic defenses), for example: 
• Diabetes mellitus 
• Immune deficiency or immune compromised states. 
A pathogenesis of bacterial meningitis is inflammatory reaction 
induced by invading bacteria, most often due elevated CSF cytokines and 
chemokines
 [5]
. The inflammatory reaction is severe in the subarachnoid 
space over the brain and around the cisterns (base of the brain). It may 
extend along the perivascular spaces into the brain and spinal cord but 
rarely breaks into the parenchyma of the brain. 
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Fig-1: PATHOPHYSIOLOGIC CASCADE IN BACTERIAL 
MENINGITIS.
36
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
↑ Intra cranial 
pressure 
Pro inflammatory 
cytokines 
Leukocyte recruitment& 
CSF entrance: meningeal 
inflammation 
Blood brain barrier 
Permeability 
altered 
Cerebral 
vasculitis 
Vasogenic 
edema 
Interstitialedema Cytotoxic 
edema 
↓cerebralblood 
flow ischemia 
↓ Global perfusion 
Release of 
Excitatory amino 
acids 
Neuronal injury 
Apoptosis 
Septic shock and 
systemic effects of 
inflammatorycytok
ines 
Endothelial damage 
23 
 
The classical clinical triad of meningitis consists of fever, headache 
and neck rigidity. Nausea, vomiting, phonophobia, photophobia are 
usually seen. With the disease progression, the sensorium becomes 
clouded and stupor. Convulsive seizures is often an early symptom (20%-
40% cases), especially in children. 
 The temperature is elevated at 101°F to 103°F. The pulse is usually 
rapid and there is increased respiratory rate. There is nuchal rigidity, 
Kernig’s sign (resistance offered to leg extension) and Brudzinski’s signs 
(resistance to forward flexion of the neck). The above signs may be 
absent in newborn and elderly. Tendon reflexes are often decreased. 
Cranial nerve palsies and focal neurologic defects are uncommon and 
usually develop several days after the onset of infection. Papilledema 
may develop if the meningitis persists for more than a week otherwise 
optic disc is normal. 
 The WBC count is increased and it is usually in the range of 
10,000/mm
3
 to 30,000/mm
3
. The pressure of CSF is increased and usually 
between 200 and 500 mm H2O. The CSF is cloudy because it contains a 
numerous cells, predominantly polymorphonuclear leukocytes. The cell 
count in the CSF is usually between 2,000/mm
3
 and 10,000/mm
3
. The 
protein content of CSF is increased. The sugar content is decreased 
(below 20 mg/dl). Particle agglutination testing may rapidly identify 
bacterial antigens in the CSF. 
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 Another rapid test used in the evaluation of bacterial meningitis is 
polymerase chain reaction (PCR.) of the CSF. PCR is highly sensitive 
and specific test for the detection of bacteria in CSF such as 
Streptococcus Pneumoniae. Other tests include real time PCR for rapid 
diagnosis of bacterial meningitis. Fluorescence In situ Hybridization 
(FISH) is also test for rapid diagnosis of bacterial meningitis with high 
sensitivity but it is not cost effective. FISH is of great use in identification 
of CSF samples which shows multiple bacteria after staining 
[6].
 
Neurological complications and pathological correlation in acute 
bacterial meningitis: 
I. In acute meningeal inflammation: 
A.   Pure pia-arachnoiditis: headache, stiff neck, Kernig and 
Brudzinski signs.  
B.  Subpial encephalopathy: manifests as confusion, stupor, coma, 
and  convulsions.  
C.  Cranial nerve roots involvement (Inflammatory or vascular): 
ocular palsies, facial weakness, and deafness. 
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D.  Meningeal vein thrombosis: may present as focal seizures, focal 
cerebral defects such as hemiparesis. There may be spinal cord 
infarction. 
E.  Ependymitis, choroidal plexitis 
F.  Cerebellar or cerebral hemisphere herniation: causes upper 
cervical  cord compression with quadriplegia or signs of 
midbrain–third  nerve compression. 
II. In more sub-acute and chronic forms of meningitis: 
A.  Tension hydrocephalus, due at first to purulent exudate around the 
base of the brain, later to meningeal fibrosis, and rarely to aqueduct 
stenosis. 
B.  Subdural effusion. 
C.  Extensive venous or arterial infarction. 
III. Late effects /sequelae: 
A.  Meningeal fibrosis around optic nerves causes blindness and optic 
atrophy (opticochiasmatic arachnoiditis). 
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B.  Meningeal fibrosis around spinal cord and roots causes spastic 
Paraparesis with sensory loss in the lower segments of the body 
(meningomyelitis). 
C.  Chronic meningoencephalitis with hydrocephalus. 
TREATMENT 
The mainstay of treatment is appropriate antibiotic therapy targeted to the 
causative pathogen. 
GENERAL PRINCIPLES OF THERAPY— Bacterial meningitis is a 
medical emergency. Treatment should be started early while waiting for 
results of specific diagnostic tests. Treatment can be altered according to 
the laboratory findings thereafter. 
The general requirements for choosing an antibiotic therapy for bacterial 
meningitis are
14
: 
•   Antibiotics which are bactericidal for the suspected infecting organism. 
• Antibiotics which is able to enter the CSF. 
• Based on pharmacodynamic characteristics of the antimicrobial agent, 
the antibiotic regimen with optimal bactericidal effects is selected. 
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Choice of antibiotic regimen — Antibiotic selection should be empirical 
and started soon after CSF is obtained for diagnostic testing or in 
instances of delayed lumbar puncture. The antibiotic is directed at the 
most likely bacteria based on age of the patient and associated comorbid 
illness in such patients. To assess susceptibility patterns also may be 
important. 
Depending upon the available CSF Gram staining results, the 
antibiotic selected should cover the most likely causative pathogen. In 
case of negative of gram staining results but CSF analysis results are 
consistent with the features of acute bacterial meningitis, the empirical 
antibiotic regimen should be continued. 
EMPIRICALTHERAPY — The selection of antibiotic in patients with 
suspected acute bacterial meningitis is targeted towards most likely 
bacteria which is based on the age of patient and host factors
15
. There are 
no documented randomized trials regarding the empiric therapy for 
bacterial meningitis in adult patients. Hence, empirical therapy guidelines 
are based on randomized trials in children, in vitro bacterial susceptibility 
and pharmacodynamic data, and clinical experience. 
The third-generation cephalosporins like ceftriaxone and 
cefotaxime are the beta-lactam antibiotics of choice in the empirical 
therapy of acute bacterial meningitis. These antibiotics have been 
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superior to chloramphenicol and cefuroxime based on randomized trials 
in children affected from bacterial meningitis
16
’
17,18
. These beta-lactam 
antibiotics easily cross blood brain barrier and have  relatively better  
CSF penetration and potent bactericidal activity against the most common 
pathogens responsible for majority cases of bacterial meningitis, with 
some exceptions like L. monocytogenes and few penicillin- resistant S. 
pneumoniae strains 
19,20,21
. Since there is increase in the prevalence of 
penicillin-resistant pneumococcus strains, vancomycin must be combined 
with third-generation cephalosporins (ceftriaxone or cefotaxime) as 
empirical therapy until culture and sensitivity results are available
22
. 
EMPIRICAL therapy includes. 
•    Cefotaxime — 2 gram intravenous every 4 to 6 hours. 
         OR 
•   Ceftriaxone — 2 gram intravenous every 12 hours. 
         PLUS 
•      Vancomycin — 30 to 60 mg per kg IV per day (2 or 3 divided  
  doses). 
          PLUS 
• In adult patients age more than 50 years, ampicillin — 2 gram 
intravenous every 4
th
 hourly. 
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Empirical therapy of bacterial meningitis 
AGE OF PATIENT ANTIMICROBIAL THERAPY" 
0-4 weeks Cefotaxime plus ampicillin 
0-4 weeks 3
rd
 generation cephalosporins + 
ampicillin (plus dexamethasone) 
3 months-18 years 3
rd
 generation cephalosporins + 
vancomycin (±ampicillin) 
18-50 years Third-generation cephalosporins + 
vancomycin (±ampicillin) 
>50 years 3
rd
 generation cephalosporins + 
vancomycin with ampicillin 
Immunocompromised 
individuals 
Vancomycin plus ampicillin and 
Ceftazidime 
Basilar skull fracture 3
rd
 generation cephalosporin + 
vancomycin 
Head trauma; neuro-surgery Vancomycin plus Ceftazidime 
CSF shunt Vancomycin plus Ceftazidime 
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Impaired cellular immunity 
The patients on cytotoxic chemotherapy, lymphoma patients or 
patients on high-dose corticosteroids or any causes leading to defective 
cell mediated immunity, antibiotic coverage must be directed against 
L.Monocytogenes, pneumococcus
23
 and Pseudomonas aeruginosa. 
 The appropriate antibiotic regimen for patients with adequate renal 
functions is: 
•   Vancomycin — 30 to 60 mg per kg per day intravenous (2or 3 divided 
doses). 
PLUS 
• Ampicillin — 2 gram intravenous every fourth hourly. 
     PLUS ANY ONE BELOW 
• Cefipime — 2 gram intravenous every eighth hourly. 
      OR 
• Meropenem — 2 gram intravenous every eighth hourly. 
Nosocomial meningitis: 
 Empirical therapy for nosocomial meningitis should be directed to 
cover both gram-positive bacteria and gram-negative bacteria (mainly 
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Pseudomonas aeruginosa and Klebsiella pneumoniae).  
 The appropriate antibiotic regimen in patients with adequate renal 
functions is: 
•    Vancomycin — 30 to 60 mg per kg per day IV (in 2 or 3 divided  
     doses). 
       PLUS 
• Ceftazidime— 2 gram intravenous every eighth hourly. 
       OR 
• Cefipime— 2 gram intravenous every eighth hourly. 
       OR 
• Meropenem — 2 gram intravenous every eighth hourly. 
Beta-lactam allergy: 
The antimicrobial therapy in patients with drug allergies is 
challenging. The importance of beta-lactam antibiotics in the treatment of 
acute bacterial meningitis has to be considered. One option is to patient 
can be desensitized who has a history of an anaphylaxis to beta-lactam 
antibiotics and who need treatment with this group of antibiotics. 
Consecutively, an alternate treatment regimen should be used while the 
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patients with drug allergy are being desensitized. The indication for 
desensitizing a patient must be based on the Grams staining and/or 
culture and susceptibility results. 
For empirical treatment in patients with profound beta-lactam 
antibiotic allergies, one of the following regimens can be started. 
• Vancomycin — 30 to 60 mg per kg per day IV (in 2 or 3 divided 
doses). 
PLUS 
• Moxifloxacin — 400 mg intravenous OD 
PLUS 
• If Listeria monocytogenes coverage is needed (in patients more than 
50 years and or in patients with impaired cell- mediated immunity), 
intravenous trimethoprim-sulfamethoxazole 10 to 20 mg per kg per 
day (of the trimethoprim component) in divided doses (every six to 
twelve hours). 
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Specific antibiotic therapy for acute bacterial meningitis: 
MICRO-ORGANISM STANDARD 
THERAPY 
ALTERNATIVES 
Haemophilus influenzae   
• β-lactamase-
negative 
Ampicillin 3
rd
 generation cephalosporin; 
chloramphenicol. 
• β -lactamase- 
positive 
3
rd
 generation 
cephalosporin 
Chloramphenicol; cefepime. 
Neisseria meningitidis Penicillin G or 
ampicillin 
Third-generation cephalosporin; 
chloramphenicol. 
Streptococcus 
pneumoniae 
  
• Penicillin(sensitive) Penicillin G or 
ampicillin 
3
rd
 generation cephalosporins; 
chloramphenicol. 
• Penicillin(intermedi
ate sensitivity) 
3
rd
 generation 
cephalosporins 
Vancomycin; meropenem. 
• Penicillin(resistant) Vancomycin plus 
3
rd
 generation 
cephalosporin. 
Meropenem 
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MICRO-ORGANISM STANDARD 
THERAPY 
ALTERNATIVES 
Enterobacteriaceae 3
rd
 generation 
cephalosporin 
Meropenem; fluoroquinolone; 
trimethoprim/sulfamethoxazole, 
or cefepime. 
Pseudomonas aeruginosa Ceftazidime or 
cefepime. 
Meropenem; fluoroquinolones; 
pipericillin. 
Listeria monocytogenes Ampicillin or 
penicillin G. 
Trimethoprim/sulfamethoxazole
. 
Streptococcus agalactiae Ampicillin or 
Penicillin G. 
3
rd
 generation cephalosporins; 
vancomycin. 
Staphylococcus aureus   
• Methicillin-sensitive Nafcillin or 
oxacillin. 
Vancomycin. 
• Methicillin-resistant Vancomycin. Linezolid, quinupristan-
dalfopristan, daptomycin. 
Staphylococcus 
epidermidis 
 Vancomycin 
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• Role of Dexamethasone in treatment of bacterial meningitis: 
Initial studies had demonstrated that there was early resolution of 
symptoms and CSF inflammatory parameters and decreased mortality 
with addition of dexamethasone to the regimen but the difference was not 
statistically significant. 
A meta-analysis studied by Van de Beek MD et al initially 
concluded that the benefit of Dexamethasone as adjunctive for bacterial 
meningitis patients remains unproven
24
. Recently the trial by deGans and 
van de Beck has shown a reduction in death rates and improved overall 
outcome if dexamethasone (10 mg) is given before the first dose of 
antibiotics and every 6 hourly for four days.    In children, fever subsided 
more rapidly and the incidence of sensorineural deafness and other 
neurologic complications were reduced (particularly in children’s 
suffering from H. influenza meningitis).Hence the treatment of childhood 
meningitis include high dose dexamethasone (0.15 mg/kg four times daily 
for 4 days), administered as early as possible. 
Studies by Tunkel and Scheld suggested the use of the 
glucocorticoids if there is septic shock. They favour the use of 
glucocorticoids in patients with severe infection at any age (very high 
CSF pressure or signs of herniation, high CSF bacterial count, and signs 
of acute adrenal insufficiency seen in Neisseria meningitides). 
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Supportive measures 
• Fluid replacement —Management of fluid and electrolyte balance 
should be done cautiously, since both over-correction and under-
correction may have adverse effects. 
• Reduction of raised intracranial pressure — Patients suffering from 
acute bacterial meningitis who are stuporous or comatose, who have 
very high intracranial pressure, may benefit by inserting an 
intracranial pressure monitor device
25
. 
  Intracranial Pressure more than 20 mm Hg must be treated.  
There is a rationale that even little elevations of intracranial pressure 
(more than 15 mm Hg) should be treated to avoid cerebral herniation 
and irreversible brainstem injury following larger elevations of 
intracranial pressures: 
• Methods to reduce intracranial pressure include head end 
elevation to 30 degrees.  
• Hyperventilation to maintain PaC02 in the range of 27 - 30 
mm Hg. 
• Use of hyperosmolar agents reducing intracranial pressure 
may increase the survival in bacterial meningitis
26
. 
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Prognosis — There is an appreciable mortality rate associated with 
bacterial meningitis even with the administration of appropriate 
antibiotics. 
Lymphocytic meningitis: 
 Tuberculosis is the most common cause of lymphocyte 
predominant meningitis especially in developing countries. Other causes 
of lymphocytic meningitis are syphilis, Lyme disease, brucellosis, 
Cryptococcosis, and other fungal infection. All these cause sub-acute or 
chronic form of meningitis. 
Out of all the above causes, tuberculosis remains a major problem 
to public in health sector   mostly seen in age group of 15-59 years. In 
developed countries as well
1
, there is a high probability for re-emergence 
of tuberculosis as a significant public health problem due to increasing 
incidence of human immune deficiency virus (HIV). The incidence 
among   patients with full-blown AIDS is almost 500 times the incidence 
in the general population for tuberculosis. (Pitchenik et al). 
The central nervous system tuberculosis contributes about 5-10% 
of all tuberculosis. Among the central nervous system manifestations, 
tuberculosis, meningitis is the most common (70-80percent) followed by 
tuberculoma
28
. 
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Risk factors for the tuberculosis meningitis are recent acute 
infectious disease in children, chronic alcoholism, diabetes mellitus, 
malignancy, long term glucocorticoids therapy and AIDS
29
. 
The most common organism responsible for tuberculous meningitis 
is mycobacterium tuberculosis. Mycobacterium bovis related meningitis 
is seen in less than 5% of cases
28
. Very few cases of tuberculous 
meningitis due to Non tuberculous mycobacterium have been reported  
inspite of increased frequency of Mycobacterium avium intracellulare in 
AIDS patients
30
. 
Pathogenesis 
Tuberculous meningitis arises as a complication of Tuberculosis 
elsewhere in the body even though extra cranial focus for infection is not 
identifiable. The evolution of tuberculous meningitis is described in two 
stages by Rich. They are: 
 i) Initial seeding in the brain or meninges by haematogenous 
dissemination of bacilli during primary infection or later due to rupture of 
caseous granuloma. 
 ii) Rupture of one of the above subpial caseous tuberculous 
focus/foci in brain is called Rich Focus. 
39 
 
The other mechanisms of tuberculous meningitis include: 
a)   Haematogenous dissemination during Primary infection or miliary 
   tuberculosis. 
b) Direct extension from nearby extra cranial sites like mastoiditis 
 tuberculosis of spine or skull bones. 
c) Intracranial lymphatic spread from cervical lymph nodes. 
Pure spinal tuberculous meningitis results from rupture of 
intramedullary tuberculous focus into the subarachnoid space which may 
be from extension of intracranial meningitis or secondary to tuberculous 
spine. 
Pathology 
Pathologically tuberculous meningitis is a meningoencephalitis 
rather than pure meningitis because infection is not confined to the 
subarachnoid space but usually penetrates the pia mater and ependyma 
and enters the underlying brain parenchyma. Pathologic process is 
characterized by basal meningitis, where a thick, gelatinous exudate 
accumulates. This exudate obliterates the pontine and interpeduncular 
cisterns. The process extends up to the meninges around the medulla, the 
floor of the 3
rd
 ventricle and subthalamic region and the under surfaces of 
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temporal lobes .The three pathologic features of tuberculous meningitis 
are: 
a) Inflammatory meningeal exudate 
b) Vasculitis of arteries traversing the exudate. 
c) Disturbance of cerebrospinal fluid flow causing hydrocephalus. 
Hydrocephalus is seen in patients who always survive more 
than 4 to 6 weeks. It can be asymmetrical or symmetrical. 
Hydrocephalus develops early, more frequent and severe in 
children compared to adults
31
.  
Microscopic examination shows the meningeal tubercles, 
consisting of a central area of caseation surrounded by epithelioid cells 
and giant cells, plasma cells, lymphocytes, and connective tissue. 
Immune complexes were found in a several number of tuberculous 
meningitis cases indicating the antigen antibody reaction and 
hypersensitivity reaction plays very significant role in pathogenesis of 
various symptoms. 
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Clinical features 
 The early manifestations of tuberculous meningitis are low grade 
fever, headache (50% cases), malaise, confusion and nuchal rigidity (75% 
cases). Kernig sign and Brudzinski sign may be present. The symptoms 
evolve slowly over a period of time in case tuberculous meningitis. In 
case of children and infants irritability, vomiting and seizures are usual 
symptoms. Neck rigidity is often absent. 
 Due to chronicity of disease process the cranial nerve palsies and 
papilledema may be seen at the time of presentation to hospital. The rapid 
onset of clinical symptoms and focal neurological deficits points towards 
haemorrhagic infarction. 
 In 75 percent of cases with tuberculous meningitis there may be a 
evidence of tuberculosis of others organs/parts of body such as lung 
(most common), small bowel, bone, kidney. 
 Untreated cases progress to deepening stupor, cranial nerve palsies, 
focal neurological deficits, raised ICP. Fatal outcome is expected in 4 to 8 
weeks from the day of onset if the infection is left untreated. 
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MRI (gadolinium enhanced) in tuberculous meningitis. There is 
contrast enhancement of the basal meninges. 
 
 
 
 
 
 
 
 
 
 
Medical Research Council (MRC) staging of TBM 
32,33
 
a) Stage 1: Prodromal phase without any neurological symptoms or signs. 
b) Stage 2: Stage where Signs of meningeal irritation with or without 
clouding of consciousness develops and cranial nerve palsies (minor) or 
neurological deficits. 
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c) Stage 3: Severe clouding of consciousness, stupor, coma, convulsions, 
gross paresis or involuntary movements. 
Diagnosis 
Initially the clinical suspicion supported by careful CSF analysis is 
the only method followed even today for the diagnosis of tuberculous 
meningitis. 
CSF analysis plays an important role in the diagnosis of 
tuberculous meningitis. Opening pressures are often but not always 
elevated
34
. 
The typical CSF finding in tuberculous meningitis is clear, 
colourless fluid and may show a cobweb clot on standing. On standing, 
high levels of protein in CSF can make it appear xanthocromic. The CSF 
protein levels usually range from 100-500 mg%
35
. Initially if the levels 
are more than 300mg%, it correlates with poor prognosis. In advanced 
xanthochromia can develop with protein content of 1000-1500mg% 
which may be due to spinal block. 
CSF glucose level is usually below 40mg / dl or 50% of the parallel 
blood glucose value. In comparing with bacterial meningitis glucose level 
is never as low or absent as seen in pyogenic meningitis
36
. Most often 
CSF sodium and chloride are reduced because of inappropriate ADH 
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secretion or an addisonian state due to tuberculosis of the adrenal glands. 
CSF chloride is of not much   diagnostic or prognostic significance. 
Microscopically CSF examination reveals pleocytosis usually less 
than 500 cells per mm
3
. Among them, predominant cells are 
lymphocytes. In the early stages polymorphonuclear cells predominate 
which is replaced by lymphocytes over a period of weeks if untreated. 
Like the clinical picture CSF responses may be atypical. CSF 
changes are dependent on the degree of sensitivity of the patient and the 
amount of tuberculin in CSF. The CSF picture initially may be normal or 
mimic pyogenic meningitis. Rarely hemorrhagic CSF has also been 
recorded which is because of subarachnoid hemorrhage. 
In patients with AIDS suffering from tuberculous meningitis CSF 
protein levels may be normal and may be occasionally acellular
37
. 
Confirmatory diagnostic tests for tuberculous meningitis include (tests 
based on detection of the mycobacterium): 
i)  CSF smears for AFB 
ii) CSF culture for AFB 
Demonstration of AFB in CSF sample is the single most important 
test for a definitive diagnosis of presence of tuberculous meningitis. 
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Limitation is that the procedure is inconsistent and often too slow for 
immediate therapeutic decisions. CSF smear for AFB is positive in only 
5-37% cases and the CSF culture for AFB is positive in 40-80% cases 
38 , 
39.
 
It is estimated that for demonstration of AFB on smear, bacterial 
load of 10,000 AFB per ml is required and for culture to be positive, there 
shall be 100 bacilli per ml of CSF. 
It is tedious and time consuming to grow tubercle bacilli on 
culture. Routine methods require 3 to 8weeks. The radiometric methods 
are much quicker and give results within a few days. 
Varieties of PCR methods are available for detection of specific 
sequences of Mycobacterium tuberculosis and even other mycobacteria. 
A PCR assay for detection of Tuberculosis is commercially 
available 
43
 . This assay is reproducible, sensitive and specific
41
. 
As compared to 5-20% positivity by AFB staining and 
mycobacterial cultures, PCR has been found to be positive in 50-70 % of 
CSF samples from cases having cardinal features of disease as well as 
biochemical/cytological evidence of neurotuberculosis
42,43,44
. 
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Newer indirect tests for diagnosis of tubercular meningitis 
Test Sensitivity Specificity Required time 
Radio labeled partition 
test 
90% to 94% 88% to 96% 48 hours 
CSF ADA level 73% to 100% 71% to 99% ≈ 24 hours 
CSF tuberculostearic 
acid level 
95% 99% ≈ 24 hours 
CSF  mycobacterial 
antigen 
79% to 94% 95% to 100% ≈ 24 hours 
CSF mycobacterial 
antibody 
27% to 100% 94% to 100% ≈ 24 hours 
PCR 83% to 100% 80% to 100% ≈ 24 hours 
Other diagnostic methods like CT or MRI may be needed in 
patients who have features of raised intracranial pressure, hydrocephalus, 
or focal neurologic deficits. Sometimes one or more tuberculoma may be 
seen. MR angiography may show vascular occlusion from granulomatous 
infiltration of the vessel walls (arteries of the circle of Willis and their 
initial branches). 
47 
 
 
 
 
 
 
 
 
 
 
 
Tuberculoma in the deep parenchyma of parietal hemisphere 
Other forms of CNS Tuberculosis are: 
• Tuberculous serous meningitis  
• Tuberculoma  
• Myeloradiculitis 
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Management  
It is very important to treat tuberculous meningitis as early as 
possible to prevent neurological sequelae and mortality. With proper 
early treatment the disease is treatable and preventable. 
Chemotherapy  
  Based on drug efficacy and toxicity the anti-tubercular drugs are 
classified into first-line and second line drugs. The first line anti-
tubercular drugs are rifampin(R), isoniazid (H), pyrazinamide (Z), 
ethambutol (E), and streptomycin(S). Second line agents are para-
aminosalicyclic acid, ethanolamine, cycloserine, kanamycin, 
capreomycin and amikacin. Newer second line agents like 
fluoroquinolones (ciprofloxacin or ofloxacin) and macrolides 
(clarithromycin and azithromycin) are used in multidrug resistant (MDR) 
cases and in case of intolerant first line agents. Isoniazid, pyrazinamide, 
and ethambutol have better CSF penetration compared to others drugs. 
Treatment regimens 
 The pharmacotherapy consists of combination of anti-tubercular 
drugs. World Health Organisation has recommended the use of four anti-
tubercular drugs (HRZE) for 2 months followed by two drugs (HR) for 
next 6 to 7 months in the treatment of tuberculous meningitis. The above 
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same regimen is followed for tuberculoma and spinal disease. The current 
United Kingdom guidelines recommends for 12 months anti-tubercular 
regimen in uncomplicated cases of tubercular meningitis. The American 
Thoracic society recommends a course of 2 months of HRZE, followed 
by 4 months of HR and in case of children for 10 months.  A recent study 
in South India has inferred that directly observed treatment, short course 
(DOTS) is effective regimen in neurotuberculosis. (Venugopal etal Indian 
J of Tb). 
Recommended anti-tuberculosis (first line) drugs: 
Drug   Usual Daily dosage Adult dosage  
Isoniazid (H) 5 to 10 mg/kg 300 mg 
Rifampin (R) 10 to 12 mg/kg 450 to 600 mg 
Pyrazinamide (Z) 25 to 30 mg/kg 1 to 1.5 gram 
Ethambutol (E) 15 to 25 mg/kg 800 mg 
Streptomycin (S) 15 to 20 mg/kg 0.75 to 1 gram 
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Multidrug-Resistant (MDR) Neurotuberculosis 
Exact incidence of MDR neurotuberculosis is not known due to 
difficulty in isolating mycobacterium from CSF. The prevalence of MDR 
in other forms of tuberculosis is 13%. Most commonly MDR tubercular 
meningitis is seen in immunocompromised patients due to HIV infection. 
The organism should be isolated and tested for drug sensitivity. At least 2 
sensitive drugs should be continued for a full course of 18 to 20 months. 
Role of corticosteroids in neurotuberculosis 
Indications   
Clinical  i. Stage 2 or 3 disease 
ii. Raised intra-cranial pressure 
iii. Focal neurological deficit 
iv. Tuberculous encephalopathy 
Radiological  i. Cerebral or perilesional oedema 
ii. Hydrocephalus 
iii. Infarcts 
iv. Opto-chaismaticar achnoiditis 
CSF Rising CSF protein suggesting spinal block 
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Dosage and duration: 
Adults: Prednisolone -60 mg/day or 1 mg/kg/day. 
         Dexamethasone- 8 to 16 mg/day. 
The drugs are administered for 3 to 6 weeks, and then slowly tapered over 
2 to 4 weeks depending upon the clinical response. 
Surgical intervention in tuberculous meningitis 
Progressive hydrocephalus refractory to medical line of treatment 
or deterioration of conscious level is the urgent indications for CSF 
diversion by ventriculo-peritoneal shunt (VP). Surgical excision of 
tuberculoma is indicated in cases of optic pathway compression resulting 
in visual impairment, Spinal cord decompression in tuberculosis of spine 
causing spondylitis. 
Prognosis  
The important factor is clinical stage at commence of treatment. 
Other important prognostic factors are extremes of age and co existing 
miliary tuberculosis. Children  are more prone for sequelae (25 to 50 % of 
cases), which include mental regression, behavioral abnormalities, 
seizures, visual and auditory impairment, cranial nerve palsies, movement 
disorders, hemiparesis or Para paresis or quadriparesis. 
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Syphilitic meningitis 
 Meningeal syphilis, meningovascular, and parenchymal syphilis 
forms the major clinically symptomatic syphilis. 
Evolution of Neurosyphilis 
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Meningeal Syphilis  
Symptoms of meningeal involvement often develop within the first 
2 years. The most common symptoms are headache, nuchal rigidity, 
cranial nerve palsies, seizures, and altered sensorium.  The patient is 
afebrile, unlike the case in tuberculous meningitis. The symptoms vanish 
over a period of days to weeks. 
Meningovascular Syphilis  
It is the most common type of neurosyphilis .This type of disease is 
considered when a young individual has one or more cerebrovascular 
accidents (35 %), the sudden development of hemiplegia, aphasia, 
sensory loss and visual impairment. The clinical syndrome occurs 6 to 7 
years after the original infection, but sometimes as early as nine months 
or 10 to 12 years late.  
The CSF findings are an elevated cell count, elevated protein, and 
gamma globulin plus a positive serological test. 
 Most common site of infarction is in the distal territories of 
medium and small-caliber lenticulostriate branches (Heubner arteritis), of 
the middle and anterior cerebral arteries. Most characteristic feature is 
internal capsular lesion, extending to basal ganglia followed by lesions 
adjacent to the lateral ventricles. Small, benign lesions are usually seen in 
the caudate nucleus and lenticular nucleus.  
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Syphilitic Meningoencephalitis (Paretic Neurosyphilis General 
Paresis, Dementia Paralytica 
The general setting of this form of cerebral syphilis is a long-
standing meningitis; as remarked above, some 15 to 20 years usually 
separate the onset of general paresis from the original infection.  
Since syphilis is acquired mainly in late adolescence and early 
adult life, the middle years (35 to 50) are the usual time of onset of the 
paretic symptoms.  
The clinical picture in its full blown disease includes dysarthria, 
dementia, myoclonic jerks, action tremor, seizures, hyperreflexia, 
Babinski signs, and Argyll-Robertson pupils (ARP) 
47
. Other symptoms 
are hemiplegia, hemianopia, cranial nerve palsies, and convulsions. The 
prominent focal signs of unilateral frontal or temporal lobe disease may 
be prominent (Lissauer’s cerebral sclerosis).   
The blood serology for the organism is positive in most of the 
cases. The CSF is abnormal in most of the cases, usually with 10 to 200 
cells/mm
3 
(lymphocytes, plasma cells, and mononuclear cells); a total 
protein of 40 to 200 mg/dl; an elevated gamma globulin. The gamma 
globulin (oligoclonal IgG) represents a specific antibody response to the 
pathogen. 
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 The pathologic changes are thickening of meninges, cerebral 
atrophy, enlarged ventricles enlargement, and granular ependymitis. 
Microscopic examination shows perivascular lymphocytosis, plasma 
cells, and mononuclear cells; there are many rod-shaped microgliacytes 
and enlarged astrocytes in parts of the cortex in the place of neuronal 
loss; mononuclear cells show iron deposition. The findings are more 
obvious in in the frontal and temporal lobes. Meningeal fibrosis leading 
to obstructive hydrocephalus is present in several cases. 
The prognosis in early treated cases is fairly good; 35 to 40 % of 
patients made some occupational readjustment; in another 40 to 50%, the 
disease was arrested but the patient was left dependent.  
Diagnosis: 
 CSF abnormalities like pleocytosis and reactive CSF VDRL tests 
supporting the clinical evidence are basis for diagnosis. The CSF VDRL 
is the gold standard for diagnoses
48
. The treponemal antibody tests, such 
as CSF fluorescent treponemal antibody absorption test are more 
sensitive. 
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 Treatment of Neurosyphilis (CDC guidelines) 
49 
 
Recommended 
regimen  
 
Adults  Aqueous crystalline penicillin G. 
Dose: 18-24 MU IV/day in divided doses or 
continuous infusion for 10 to 14 days. 
Children  Aqueous crystalline penicillin G, 2 to 3 
lakhs/kg/day, given as 50,000 U/kg IV every 4-6 
hours for 10 days. 
Alternative treatment regimen for adults: 
Procaine penicillin, 2.4 Million units intramuscular once daily along with 
oral probenecid 500 mg  in 4 divided doses for a period of 10 to 14 days. 
Alternative drugs (for individuals allergic to penicillin): 
Doxycycline: 100 mg orally BD for 14 days. 
Tetracycline: 500 mg orally QID for 14 days. 
Erythromycin: 40mg/kg/day orally QID for 14 days. 
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Cryptococcal meningitis 
 Cryptococcosis (torulosis) is one of the most commonly 
encountered fungal infections of the CNS. The organism causing is 
Cryptococcus neoformans. The organism is a soil fungus found in the 
birds’ droppings (especially pigeons). The respiratory tract is the common 
port of entry for organism, in some occasions the skin and mucous 
membranes. 
CNS Cryptococcosis has many distinctive clinical Features. The 
most common early complaints are headache, nausea, and vomiting; 
altered sensorium is present in about 50% cases
50
. Some patient presents 
with symptoms of gradually increasing intracranial pressure due to 
hydrocephalus (Papilledema is seen 50% cases) or with an altered 
sensorium, dementia, cerebellar ataxia, or Paraparesis (spastic). A pure 
motor hemiplegia, like that due to hypertensive lacunae, has been the 
most common type of stroke due to meningovascular lesions. 
Predisposing factors are the diseases that supress immunity such as 
Lymphoma (Hodgkin disease), leukaemia, carcinoma, tuberculosis, and 
other debilitating conditions in 50% cases. It has been estimated that 6 to 
12% of AIDS patients are vulnerable to Cryptococcal 
meningoencephalitis. 
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Laboratory investigations: 
The CSF shows a varying lymphocytic pleocytosis, (less than 50 
cells/mm
3
), except in patients with AIDS where there might be few or no 
cells seen (75% have 5 or less cells /mm
3
). The initial CSF picture of 
polymorphonuclear cells is rapidly changed to a lymphocytic 
predominance. The glucose is reduced in 75% of cases except in AIDS 
patients where it might be normal. The protein may reach high levels. 
Diagnosis is confirmed by finding the organism or its antigens in the 
CSF. Rapid diagnostic tests like Latex agglutination test that detects 
Cryptococcal polysaccharide antigen in CSF are widely available 
(specificity of 90%).  
Treatment  
Amphotericin B, 0.5 to 0.7 mg per kg per day IV is drug of choice 
in patients without AIDS. Blood urea nitrogen should be monitored and 
drug is discontinued if blood urea nitrogen reaches 40 mg/dl and resumed 
when it normalizes. 
The addition of flucytosine (150 mg/kg per day) with amphotericin 
B (0.3 to 0.5 mg/kg per day) has fewer incidences of failures or relapses. 
Added benefits with combination are more rapid CSF sterilization and 
less nephrotoxicity. The course of therapy is for at least 6 weeks and 
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sometimes longer if CSF cultures for organism remains positive. This 
combination regimen has a Cryptococcal meningoencephalitis cure rate 
of 75 to 85% in immunocompetent   patients and is less effective in 
patients with AIDS. Fluconazole (up to 400 mg daily orally) or 
itraconazole (up to 200 mg/day orally) are substitutes to flucytosine in 
AIDS patients and are quite more effective to prevent relapse when taken 
indefinitely
51
. Mortality is about 40% from Cryptococcal 
Meningoencephalitis independent of AIDS or other diseases. 
Aseptic meningitis: 
 The most common cause of aseptic meningitis is viral infection. 
Other causes are carcinomatous meningitis and drug induced 
hypersensitivity reactions. 
Etiology  
The most important viruses are enteroviruses (coxsackie viruses, 
echoviruses, and human enteroviruses 68-71) make up to 80% of cases. 
Other viruses responsible for disease are mumps, herpes simplex virus-2, 
lymphocytic choriomeningitis, adenovirus, arthropod borne viruses, and 
HIV etc
52
. 
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Causes of chronic and recurrent aseptic meningitis: 
Infectious causes 
• Tuberculosis and atypical mycobacterial. 
• Fungal infections like (Cryptococcal, coccidian, histoplasmosis, 
blastomyces). 
• Nocardia 
• HIV 
• Herpes type 2 (known as recurrent Mollaret meningitis). 
• Lyme disease 
• Syphilis 
• Brucellosis 
• Epidural abscess or hematoma 
• Incompletely treated bacterial meningitis 
Granulomatous and vasculitis causes 
• Sarcoidosis 
• Wegener granulomatosis 
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• Behcet’s disease 
• Vasculitis 
Neoplastic causes 
• Carcinomatous 
• Lymphomatous 
Chemical causes 
• Leakage from cerebral or spinal epidermoid tumor, dermoid cyst, 
craniopharyngioma, or teratoma 
• Instillation of irritative substances by lumbar puncture, spinal 
anesthesia or surgery. 
Idiopathic 
• Vogt-Kayanagi-Harada disease 
• No cause determined in one-third of cases 
Diagnosis  
Clinical syndrome of aseptic meningitis consists of fever, 
headache, and signs of meningeal irritation along with lymphocytic 
pleocytosis in cerebrospinal fluid analysis.  
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Varying degrees of lethargy, irritability, and drowsiness may occur. 
Confusion, stupor, and coma are seen in case of encephalitis rather than 
meningitis. Photophobia and pain on movement of the eyes 
(ophthalmoplegia) are common associated features. 
Rigidity of the neck and spine on forward bending points to 
presence of meningeal irritation (meningismus), but at first it is often 
unnoticed. In this clinical syndrome the Kernig sign and Brudzinski sign 
are often absent in the presence of manifest viral meningitis. 
 Other symptoms and signs of systemic effects of the invading virus 
may be present. These include sore throat, nausea and vomiting, easy 
fatigability, pain in the back and neck, cough, conjunctivitis, vomiting, 
diarrhoea, rash, adenopathy, etc. 
The typical CSF profile is a lymphocytic pleocytosis as it is seen 
with other lymphocytic (tuberculosis), with normal glucose 
concentration, normal or mildly elevated protein level
53
. 
As a rule glucose content of cerebrospinal fluid is normal in case of 
aseptic meningitis. Therefore CSF picture showing low glucose 
concentration in conjunction with a lymphocytic or mononuclear 
pleocytosis points to tuberculous or fungal aetiology of meningitis or 
certain non-infectious disorder (sarcoid, neoplastic) meningitis. 
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Treatment  
Acyclovir may be used in HSV-1 AND 2, EBV, VZV infection and 
HAART in HIV meningitis. But viral meningitis is usually self-limiting 
illness. Symptomatic care, like relief of headache, bed rest, adequate 
nutrition and maintaining fluid and electrolyte balance form the mainstay 
of therapy. 
CSF CORTISOL and its role in meningitis: 
Cortisol is the main corticosteroid circulating in humans. 
Corticosteroids are synthesized in adrenal cortex from cholesterol. 
The physiological actions of cortisol are: 
• Maintaining electrolyte and water balance 
• Regulation of carbohydrate metabolism (gluconeogenesis) 
• Maintenance of vascular response to catecholamines. 
• Anti-inflammatory activity and suppression of immune response.  
Cortisol secretion is dependent on the integrity of the 
hypothalamic-pituitary-adrenal (HPA) axis and the steroid exerts a 
negative feedback on its own synthesis through this axis. Cortisol 
measurement is thus an important parameter in the investigation of 
apparent HPA dysfunction. 
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This picture shows interrelationship of free and bound cortisol 
 
 
 
 
 
 
Cortisol is bound in the circulation to alpha gloubulin called 
transcortin or corticosteroid binding globulin. The half-life of cortisol in 
the circulation is longer (about 60-90 minutes), with approximately 1% 
excreted unchanged in the urine. This excreted fraction is called urinary 
"free cortisol” and if renal function is normal, will reflect the level of 
circulating non-protein bound cortisol. Most immunological methods 
employed for the determination of urinary free cortisol omit 
chromatographic steps thereby co-measuring cortisol metabolites. After 
metabolic breakdown, mainly in the liver, cortisol is excreted into the 
urine as dihydrocortisol and tetrahydrocortisol derivatives conjugated to 
glucuronicacid
44
. 
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The circulating cortisol concentration is normally subject to a 
circadian rhythm, with the maximum level being reached in morning at 8-
9 a.m. and the minimum around midnight(12am)
55
. 
Cortisol is the major glucocorticoid in humans, maintaining the 
stress reaction of the body to all kinds of physical and psychological 
discomfort. Increase in cortisol secretion can take place very quickly, 
within minutes in acute stress conditions, and can stay at high levels for 
long periods, sometimes days, months, and even years in chronic disease 
conditions
56
. 
Michal Holub et al have shown that CSF cortisol levels in patients 
with bacterial meningitis are highly elevated and correlate with disease 
severity
4
. 
The mechanism behind increased CSF cortisol in bacterial 
meningitis is associated with systemic inflammation, intense stress 
response and compromised blood brain barrier. 
During critical illness, cortisol-binding globulin and albumin blood 
levels decrease by about 50%, leading to an increase in biologically 
active free cortisol. 
It was suggested that balance between CSF cortisol and blood 
cortisol levels are controlled by active efflux of the hormone from the 
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brain. Perturbation of this mechanism by inflammation, together with 
reduced ability of brain cells to metabolize sterol molecules, may lead to 
persistent increase in CSF cortisol
4
. 
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MATERIALS AND METHODS 
Design: Cross sectional observational study in patients of suspected 
meningitis during August 2013 to July 2014. 
Sample Size: 50 Patients which includes 40 study patients and 10 
control subjects. 
Case Definitions: Patients with clinical suspicion of meningitis 
presenting with fever, vomiting, altered sensorium and nuchal rigidity. 
Inclusion Criteria 
1. Age of patients more than 16 years 
2. Patient with clinically suspected meningitis and confirm with lumbar 
 puncture. 
Exclusion Criteria 
1. Partially treated cases with antibiotics before admission. 
2. Patients treated with corticosteroids before admission. 
3. Traumatic lumbar punctures for CSF collection. 
Ten patients without any pre-existing neurological disorders will 
be included as controls.  
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All the patients were thoroughly examined clinically by preformed 
proforma and investigated as follows: 
Working Indices: 
Investigation 
1. Hematological 
             a) Complete haemogram. 
2. Hepatic function tests 
3. Renal function tests 
4. Serum electrolytes 
5. Random blood sugar: at the time of lumbar puncture 
6. Chest X-ray PA view 
7. Blood culture 
8.    CSF 
      a)  Cytochemical analysis including- cell count, cell type, protein,                            
 sugar 
      b) CSF- CORTISOL estimation by chemiluminescent assay. 
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      c) CSF- gram stain and Zeil Nelson stain 
      d) CSF- culture for mycobacteria and pyogenic organisms 
       e) CSF - TB PCR, HSV PCR, India ink, Cryptococcal Ag, ADA as 
   and   when required. 
9. Serum cortisol. 
Analysis of CSF: 
A fresh sample of CSF collected in heparinised vial obtained by the 
lumbar puncture. 
The different types of meningitis will be categorized as follows, 
according to cytochemical parameters
57
.
 
1) Bacterial meningitis: 
Protein: more than 45 mg /dl 
White blood cells: 10/microliter to 10000 /microliter: neutrophil 
predominate 
glucose: < 40mg/dl 
CSF/ serum glucose: < 0.4 
Cloudy or turbid appearance 
 Gram’s stain and culture were done 
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2) Tubercular meningitis: 
                               Protein: 0.1-0.5 g/L. 
                               Cell counts: 10-500 cells/microL; lymphocytic  
   pleocytosis. 
                               Glucose: 20 - 40 mg/dl. 
                               AFB and culture will be done. 
3) Aseptic meningitis: 
                              Protein: 20-80 mg/dl. 
                              Glucose: normal to decrease. 
                              Cell counts: 25-500 cells/microliter 
                              Cell types: lymphocytic pleocytosis. 
CSF CORTISOL Activity: 
CSF-CORTISOL activity was estimated in all 40 cases by direct 
chemiluminescent assay and comparison was made among neutrophilic 
meningitis, lymphocytic meningitis, aseptic meningitis and controls. 
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Method: For in vitro diagnostic use in the quantitative determination of 
cortisol levels in CSF using the ADVIA Centaur CP system by direct 
chemiluminescent assay.  
Principle: The ADVIA Centaur CP Cortisol assay is a competitive 
immunoassay using direct chemiluminescent technology. Cortisol in the 
patient sample competes with acridinium ester labeled cortisol in the Lite 
Reagent for binding to polyclonal rabbit anti-cortisol antibody in the 
Solid Phase. The polyclonal rabbit anti-cortisol antibody is bound to 
monoclonal mouse anti-rabbit antibody, which is covalently coupled to 
paramagnetic particles in the Solid Phase. 
Specimen Collection and Handling: 
The following recommendations for handling and storing CSF 
samples are furnished by the Clinical and Laboratory Standards Institute 
(CLSI, formerly NCCLS):5 
1. Universal precautions are taken for collecting all CSF samples. 
2. Allow samples to clot adequately before centrifugation 
3. Samples tubes are stoppered and always kept upright. 
4. Do not use samples that have been stored at room temperature for 
longer than 8 hours. 
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5. The CSF are refrigerated at 2° to 8
o 
C if the assay is delayed and is 
not completed within 8 hours. 
6. The CSF samples are freezed at or below -20°C in case sample is 
not assayed within 48 hours of collection. 
7. Freeze samples only once and mix thoroughly after thawing. 
Before placing samples on the system ensure that samples have the 
following characteristics: 
A. Samples are free of fibrin or other particulate matter. If 
present remove particles by centrifugation. 
B. Samples are free of bubbles or foam. 
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Table- :Reagent preparation: 
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Loading Reagents: 
Ensure that the system has sufficient primary and ancillary reagent 
packs. 
Mix all primary reagent packs by hand before loading them onto 
the system. Visually inspect the bottom of the reagent pack to ensure that 
all particles are dispersed and suspended. Load the primary reagent packs 
in the primary reagent area. You can use the arrows on the end label as a 
placement guide. However, left, center, and right placement of the 
primary reagent packs is not required, because the ADVIA Centaur CP 
System has only one reagent probe. The system automatically mixes the 
primary reagent packs to maintain homogeneous suspension of the 
reagents.  
Test Procedure 
The system automatically performs the following steps: 
1. Dispenses 20 microliter of sample into a cuvette. 
2. Dispenses 50 microliter of Lite Reagent and 250 microL of 
Solid Phase and incubates for 9 .66 minutes at37°C. 
3. Separates, aspirates, and washes the cuvettes with Wash 1. 
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4. Dispenses 300 microliters each of Acid Reagent (R1) and 
Base Reagent (R2) to initiate the chemiluminescent reaction. 
5. Reports results according to the selected option, as described 
in the system operating instructions. 
Table- Reference Values for CSF-CORTISOL:                                              
NORMAL < 2 microgram/dl 
NONBACTERIAL 2-10 microgram/dl 
BACTERIAL >10 microgram/dl 
It is recommended that each laboratory establish its own normal range 
representing its patient population. 
Study Design: Cross sectional observational study. 
ETHICAL CLEARANCE: 
Ethical clearance was obtained from the Institutional Ethical Committee.  
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Statistical Analysis: 
The data will be tabulated and analyzed. The quantitative data will 
be summarized in excel sheet. 
Mean, Median, Standard Deviation will be estimated, in order to 
know the association between CSF cortisol levels, cytochemical analysis 
and culture results. 
In all the tests “p” value less than 0.05 and 0.01 will be accepted as 
statistically significant and highly significant, respectively. SPSS16 
software will be used. Microsoft word and excel will be used for 
preparation of graphs and charts.  
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Results  
Table-1:   Age-wise Distribution of cases 
 
Age-wise Distribution Frequency % distribution 
16-20 14 35% 
21-25 5 13% 
26-30 3 8% 
31-35 4 10% 
36-40 4 10% 
41-45 2 5% 
46-50 3 8% 
>50 5 13% 
Total 40 100% 
 
 
 
 Chart -1 
 
 
 
 
 
 
In our study the peak incidence of meningitis is seen in 16
age.  
TABLE -2: Distribution among gender
Overall Gender Distribution
Gender 
Female 
Male 
Total 
 
78 
 
     
No of Cases Percentage
14 35%
26 65%
40 100%
-20 years of 
 
 
 
 
 Chart-2: 
 
 
 
 
 
 
 
In the present study male were 65% and female cases were35%. Male to 
female ratio is 1.85:1
Table -3: Gender distribution across overall meningitis in sample
  
Meningitis Diagnosis
Non Bacterial 
Bacterial 
Total 
79 
 
Gender 
%   
 Male Female 
35% 23% 
30% 13% 
65% 35% 
 
  
Total 
58% 
43% 
100% 
 Chart -3: 
 
 
 
 
 
 
 
 
In our study, in 65% were male patients and 35% were female patients 
suffering from meningitis. Out of this, 23% and 35% for non
meningitis respectively.in case of bacterial, male: f
30% and 13% respectively. 
 
 
 
 
80 
emale incidence was 
 
-bacterial 
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Table- 4: Gender Distribution across Meningitis in the sample: 
  Gender 
Meningitis Diagnosis Male Female Total 
Neutrophilic 12 5 17 
Lymphocytic 9 7 16 
Aseptic 5 2 7 
Total 26 14 40 
In our studies out of 40 patients 17 cases had neutrophilic meningitis, 16 
cases had lymphocytic meningitis and 7 cases had Aseptic meningitis. 
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Table 5-   Analysis of clinical symptoms
Clinical symptoms
Fever 
Headache 
Vomiting 
Altered sensorium
Convulsions 
Chart-4 
 
 
 
 
 
 
In our studies among 40 patients of meningitis, all patients had fever 
(100%).headache was present in 29 patients (72.5%), vomiting was seen 
in 27 patients (67.5%), various 
patients (52.5%), convulsions in 14 
82 
analysis of clinical symptoms
 
 no of cases 
40 
29 
27 
 21 
14 
stages of altered sensorium is seen in 21 
cases (35%). 
analysis of clinical 
symptoms
percentage 
100% 
72.5% 
67.5% 
52.5% 
35% 
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Table6: Analysis of clinical signs 
Signs No. of cases Percentage 
Signs of meningeal irritation 40 100% 
 Altered sensorium 21 53% 
        Drowsiness  15 37.85% 
        Irritability  4 10.09% 
        Stupor  2 5.04% 
        Coma  0 0 
Cranial nerve involvement 4 10% 
        6
th
 nerve palsy 3 7.5% 
        7
th
 nerve palsy 1 2.5% 
Motor system involvement   
        Hemiparesis  1 2.5% 
Among the 40 cases of meningitis, signs of meningeal irritation were seen 
in all (100%) of cases. Altered sensorium was seen in 21 cases (53%). 
Cranial nerve palsies were present in 4 cases, 3 were 6
th
 nerve palsy and 1 
was facial nerve palsy.  
 53%
Chart:5 
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100%
10%
2.50%
analysis of clinical signs
 
 
 
 
 
 
meningeal irritation
altered sensorium
cranial nerve palsies
hemiparesis
 Analysis o
Table-7:  Average of days of fever across overall meningitis
 
Overall Meningitis
Non Bacterial 
Bacterial 
Overall Mean 
Chart-6: 
 
 
 
 
 
 
 
In the present study ther
the total of days of fever in bacterial and nonbacterial meningitis
85 
f Individual Clinical Symptoms
 Mean
3.48
3.47
3.48
e was no significant correlation between 
 
 
 
 
 
 
. 
 Chart-7: Average of Days of Fever across Neutrophilic, Lymphocytic,
 
 
 
  
 
 
 
 
In the study there was no correlation between the days of fever 
neutrophilic, lymphocytic and aseptic meningitis.
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Aseptic meningitis 
 
 
and 
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Table-8: Distribution of Vomiting Instances across Overall 
Meningitis Diagnosis 
Overall Meningitis Diagnosis % 
Non Bacterial 83% 
Bacterial 59% 
Overall Sample 73% 
 
Chart-8: % of Vomiting Instances across Overall Meningitis 
Diagnosis 
 
 
 
 
 
 
In our study, among the 40 meningitis patients 59% of bacterial 
meningitis had vomiting and 89 % of nonbacterial had vomiting. 
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Chart-9: Distribution of Vomiting Instances across Neutrophilic,    
Lymphocytic, Aseptic meningitis 
 
 
 
 
 
 
 
 
In our present study incidence of vomiting was more among 
lymphocytic meningitis (88%) compared to neutrophilic (59%) 
meningitis and aseptic (71%) meningitis. 
 
 
 
 Table-9: Distribution of headache instances across overall 
 
Overall Meningitis
Non Bacterial 
Bacterial 
Overall Sample 
 
Chart-10: 
 
 
 
 
 
 
 
In the study percentage incidence of headache was more among bacterial 
(94%) than nonbacterial (48%) meningitis
89 
 
48%
94%
68%
. 
meningitis 
% 
 
 
 
 Chart-11: 
 
 
 
 
 
 
 
In the study headache
meningitis.In case of lymphocytic meningitis and aseptic meningitis the 
headache was present in 38% and 71 
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 was common was present in 94% of neutrophilic 
% patients respectively. 
 Table-10:Distribution of ALTERED SENSORIUM Instances across
     Overall Meningitis
  Overall Meningitis
Non Bacterial 
Bacterial 
Overall Sample
Chart-12: 
 
 
 
 
 
 
 
Over incidence of altered sensorium was 53%. Nonbacterial meningitis 
(57%) incidence was more in comparison with no 
meningitis. 
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 %
57%
47%
 53%
 
 
 
 
 
bacterial (47%) 
 Chart-13 
 
 
 
 
 
 
 
 
The presence of altered sensorium was more in 
(63%) compared to
present study. 
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Lymphocytic meningitis 
 neutrophilic meningitis and aseptic meningitis in the 
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Table-11: Distribution of Instances of Seizure across Overall 
Meningitis 
  
  PERCENTAGE  
% of Instances of SEIZURES Non Bacterial Bacterial Total 
0 70% 59% 65% 
1 22% 6% 15% 
2 4% 29% 15% 
3 0% 6% 3% 
6 4% 0% 3% 
Total 100% 100% 100% 
 
 In our study, 30% of non-bacterial meningitis and 41% of 
bacterial meningitis had seizures. 
 
 
 Chart-14 
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 Chart-15: 
 
 
 
 
 
 
 
 
 
 
 
 
 Furthermore 22% of non
episode of seizure respectively. 35% of bacterial meningitis group had 
more than one episode of seizure as compared to non
group (8%). 
95 
-bacterial and 6% bacterial had one 
-bacterial meningitis 
96 
 
Table12: Cytological and bio chemical parameters of blood and CSF 
in different group of meningitis patients 
 
Parameters  Normal ranges Neutrophilic 
meningitis 
Lymphocytic 
meningitis 
Aseptic 
meningitis 
Blood      
WBC 
count(cells/mm
3
) 
4000-11000 14900 
(11824-18635) 
7350 
(4160-10118) 
6950 
(3630-7950) 
CSF     
Cell 
count(cells/mm
3
) 
<5 210 (90-400) 182 (85-300) 32 (20-40) 
Cell type 
(predominant) 
Usually 
lymphocytes 
Neutrophils Lymphocytes Lymphocytes 
Protein (mg/dl) 20-45 mg/dl 120 (80-165 ) 119 (90-160 ) 39 (30-50 ) 
Glucose (mg/dl) >2/3 of blood 
glucose 
40 (26-69) 42 (26-86) 74 (60-82) 
CSF/Serum 
glucose ratio 
>0.6 0.28 (0.288-0.34) 0.3 (0.28-0.42) 0.64 
(0.62-0.66) 
In the present study among 40 meningitis cases, the WBC count in 
neutrophilic meningitis is high compared to lymphocytic meningitis and 
aseptic meningitis. Among the neutrophilic meningitis cases mean CSF 
cell count is 210cells/mm
3
, mean protein level is 120 mg/dl, mean CSF 
glucose is 40 mg/dl and mean CSF/Serum glucose ratio is 0.28. 
 Table -13: Average of Protein, Sugar and RBS across Neutrophilic, 
Lymphocytic, Aseptic meningitis
Meningitis Diagnosis
Neutrophilic 
Lymphocytic 
Aseptic 
Overall Sample 
In the present study neutrophilic a
protein was 119.94
significant difference when compared with aseptic meningitis.
the CSF glucose was low in neutrophilic and lymphocytic meningitis 
(≈40mg/dl) in comparison with aseptic meningitis (74
Chart-16: 
 
 
 
 
 
97 
 
 PROTIEN SUGAR 
119.94 40.00 
119.56 42.81 
39.29 74.00 
105.68 47.08 
nd lymphocytic meningitis mean 
mg/dl and 119.56mg/dl respectively. There 
mg/dl
RBS 
140.76 
140.13 
118.57 
136.63 
was 
 Similarly 
). 
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Table-14: CSF Cortisol Level across Meningitis Diagnosis 
Overall Meningitis Diagnosis Statistics CSF Cortisol Levels 
Non Bacterial 
Mean 3.8 
Median 4.0 
Maximum 5.0 
Minimum 2.0 
No of Cases 23 
Bacterial 
Mean 13.1 
Median 14.0 
Maximum 17.0 
Minimum 4.0 
No of Cases 17 
Total 
Mean 7.7 
Median 5.0 
Maximum 17.0 
Minimum 2.0 
No of Cases 40.0 
 Mean CSF cortisol level in bacterial meningitis (13.1µg/dl) group 
was significantly higher as compared to non-bacterial meningitis 
(3.8µg/dl) and control group (1.05µg/dl). 
 Chart-17:CSF Cortisol Level across Meningitis Diagnosis
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Table-15:  CSF cortisol level across neutrophilic, lymphocytic, aseptic   
meningitis. 
The P value indicates that the means are different. 
Mean CSF cortisol level in neutrophilic meningitis was significantly high 
as compared with lymphocytic, aseptic meningitis and control group. 
It is statistically significant with p value of 0.000. 
Meningitis Diagnosis Statistics 
CSF 
Cortisol 
Levels(µg/dl) 
F value 
 
 
 
 
 
 
 
 
 
 
 
110.721 
P 
value 
 
 
 
 
 
 
 
 
 
 
0.000 
Neutrophilic 
Mean 13.06 
Median 14 
Maximum 17 
Minimum 4 
No of Cases 17 
Lymphocytic 
Mean 4.44 
Median 5 
Maximum 5 
Minimum 3 
No of Cases 16 
Aseptic 
Mean 2.29 
Median 2 
Maximum 3 
Minimum 2 
No of Cases 7 
Controls  
Mean  1.05 
Maximum  1.7 
Minimum  0.2 
No of cases 10 
 Chart 18: CSF Cortisol levels across different group of meningitis
 
 
 
 
 
 
 
 
 
The mean CSF cortisol 
13.1µg/dl, lymphocytic meningitis is
2.3µg/dl. 
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levels in neutrophilic meningitis are
4.4µg/dl and aseptic meningitis is 
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Table16- Comparison of CSF cortisol levels and neutrophilic, 
lymphocytic and aseptic meningitis 
CSF Cortisol Levels. Tukey HSD 
   Mean 
Difference (I-J) 
Std. Error Sig. (P value) 95% 
Confidence 
Interval 
          
Lower Bound Upper 
Bound 
Neutrophilic Lymphocytic 8.621* 0.688 0.000 6.94 10.3 
 Aseptic 10.773* 0.887 0.000 8.61 12.94 
Lymphocytic Neutrophilic -8.621* 0.688 0.000 -10.3 -6.94 
 Aseptic 2.152 0.895 0.054 -0.03 4.34 
Aseptic 
Neutrophilic 
-
10.773* 
0.887 0.000 -12.94 -8.61 
 Lymphocytic -2.152 0.895 0.054 -4.34 0.03 
.*. The mean difference is significant at the 0.05 level 
However the Tukey test confirm that average levels of CSF 
Cortisol is significantly higher for Neutrophilic when compared to 
Lymphocytic and Aseptic and that the average levels of CSF Cortisol is 
not significantly different between Lymphocytic and Aseptic meningitis. 
 0
5
10
15
pretreatment
Table17– CSF cortisol level in bacterial meningitis in relation to 
treatment 
 
                                                   
 
Bacterial meningitis
 
Chart -19: 
 
 
 
 
 
 
 
In the present study there was significant reduction in CSF cortisol 
levels post treatment.
103 
cortisol level
post treatment
cortisol level
Mean CSF CORTISOL levels (
 
Pre treatment Post treatment
              13.1            
 
cortisol level
µg/dl) 
 
1.2 
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DISCUSSION 
Forty cases were studied and the diagnostic utility of CSF cortisol 
was evaluated in differentiating neutrophilic meningitis and lymphocytic 
meningitis, aseptic meningitis. CSF samples from 10 subjects without any 
pre-existing neurological disorders who underwent spinal anesthesia were 
taken as controls. 
 The peak incidence of meningitis in the present study was seen in 
patients in the age group between 16-20 years. In the Michal Holub et al 
study, the mean age was 42 years 
4
in the present study the incidence in 
males was 65% and in females was 35%. In Michal Holub et al study the 
incidence in males was 61.7% and in females was 38.3%
4
. 
 In the present study, the most common symptom was fever 
(100%) followed by headache (72.5%) and vomiting (67.5 %.). In van de 
Seek D et al study, the classic triad of fever, Nuchal rigidity and change 
in mental status was present only in 44% of cases. However 95% had at 
least two of the four symptoms of headache, fever, neck stiffness and 
altered mental status
59
. In the present study, Seizures were noted in 36% 
and is comparable with Van de Beek et al study, the incidence of seizures 
was 17%
59
. In the present study, the signs of meningeal irritation were 
present in 100% of cases. Neck rigidity in 100% of cases, Kernig’s in 
105 
 
35.5% of cases and Brudzinski’s sign 8.7% of cases. In Khatua et al 
study, neck rigidity was noted in 54% case and Kernig’s sign in 40% of 
cases
60
. 
In the present study, cranial nerve involvement was seen in 4 cases 
(10%), three sixth nerve  palsy and one seventh nerve palsy which is less 
common compared to other studies done by Van de Beek et al(33%) . 
Virmani et al (27%) and Khatua et al (25%) 
59,60
. In the present study, 
Motor deficit was seen in 1 case (5.71%) where as in Diederik Van de 
Beek et al study motor deficit was observed in 23% cases
59
. 
In the present study, mean CSF cortisol levels were significantly 
higher in neutrophilic meningitis (13.06µg/dl) as compared to 
lymphocytic meningitis (4.44 µg/dl), Aseptic meningitis (2.29 µg/dl) and 
controls (1.05 µg/dl). It is statistically significant, p value being 0.0001. 
Similarly, in Michal Holub et al study, the mean CSF Cortisol was 
significant elevated in neutrophilic meningitis; ( 133nmol/ l) compared to 
aseptic (17nmo/l) and controls (10nmol/l)
4
, p value being highly 
significant (0.001). Beran et al study showed that the mean CSF cortisol 
was significantly elevated in aseptic meningitis compared to controls. In 
the present study, similar observations were made, mean CSF cortisol 
level in aseptic meningitis (2.29µg/dl) compared to controls (l.05µg/dl). 
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In the present study, it was observed that there was no significant 
difference in mean CSF cortisol levels in culture positive (l6.05) and 
culture negative (13.51)  neutrophilic meningitis, p value being 
<0.069.Only 8 patients; of bacterial meningitis showed culture positive. 
The 8 cultures were positive and the organisms were streptococcus 
pneumoniae (7), Neisseria meningitidis (1) and hemophilus influenzae 
(1). In Michal Holub et al study, it was observed that there was 
significant difference in CSF cortisol levels in culture positive(162nmol/l) 
and culture negative percent(103nmol/l). Total number of patients with 
bacterial meningitis showing culture positive was thirty five (74%) out of 
these, 14 were caused by Neisseria meningitides (40%). 11 cases were 
due to streptococcus pneumonia (31%). Others included E.coli, 
Streptococcus hemolyticus, Staphylococcus aureus, and listeria 
monocytogenes, hemophilus influenza. 
In the present study, a direct correlation was observed between 
mean CSF cortisol levels (13.06). It was statistically significant, p value 
being 0.000. In Michal Holub et al study similar observations were made, 
a direct correlation between mean CSF cortisol levels(133 nmol/l) and 
mean serum cortisol levels(939+/-534 nmol/l). That is as the CSF cortisol 
level raises, serum cortisol levels also raise. In Singhi SC et al study, free 
mean cortisol levels were significantly higher in bacterial meningitis 
compared to aseptic meningitis
4
. 
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The mean CSF cortisol pre-treatment levels (13.06) showed 
significant reduction post treatment (1.2). Similar observations were 
made in Michal Holub et al study
4
. 
In the present study, altogether 28 patients (80
%
) were admitted to 
Intensive Care Unit, with a median length of stay in ICU being 7 days 
and median length of stay in hospital was 18 days. Favorable outcomes 
were observed  in 25patients (85.7%). Three patients (8 .5%) succumbed 
and two patients (5.71%) exhibited neurological sequelae. In Michal 
Holub et al study,  altogether 40 patients (85%) were admitted to 
Intensive Care Unit with a median length of stay of 8 days (4-l 5) days 
and median length of stay in hospital being 24 days. Favorable outcomes 
of bacterial meningitis were observed in 17 patients (77%) and 7 patients 
(l 5%) succumbed within 28 days after admission, 4 patients (8%) 
exhibited severe neurological sequelae. 
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CONCLUSION 
1) CSF cortisol levels were significantly higher in bacterial meningitis 
group compared to non-bacterial meningitis group taking the cut 
off value of 10µg/dl. 
2) CSF cortisol is significantly reduced following specific treatment 
in bacterial meningitis group. This can be a useful guide in 
monitoring the response to therapy. 
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SUMMARY 
• Forty cases were studied and the diagnostic utility of CSF cortisol 
was evaluated in differentiating neutrophilic meningitis, 
lymphocytic meningitis, and aseptic meningitis. Ten subjects 
without any pre-existing neurological disorders who underwent 
spinal anaesthesia were taken as control. 
•   The peak incidence of present study was seen in patients in the age 
group between 16-20 years (35%).The mean age was 42.6 years. 
• In the present study, the incidence in males was 65 %( 26) and in 
females was 35 %( 14). 
• The most common symptom was fever (100%) followed by 
headache (72.5%) and vomiting (67.5%). 
• The signs of meningeal irritation were present in 100% of cases. 
Seizures were noted in 36% of case. Cranial nerve involvement 
was seen in 4 cases (10%). Motor deficit was seen in 1 case (2.5%). 
• Mean CSF cortisol levels were significantly higher in neutrophilic 
meningitis (13.06µg/dl) as compared to lymphocytic meningitis 
(4.44µg/dl), Aseptic meningitis (2.29µg/dl) and controls (l 
.05µg/dl). 
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• The CSF cortisol in bacterial meningitis pre-treatment levels 
showed significant reduction post treatment which was 1.2µg/dl. 
• CORTISOL activity in CSF is a rapid, relatively inexpensive and 
simple procedure can be of great value as a diagnostic marker in 
the early diagnosis of Bacterial meningitis and Nonbacterial 
meningitis, helping in early institution of appropriate treatment and 
thereby decreasing mortality and complications. 
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PROFORMA 
 
Name:                                          Age:                                      I.P.No: 
Occupation:                                  Sex: 
Address:                                        Date of admission: 
DIAGNOSIS: 
 
History of Present Illness 
 
1 Mode of onset:                        Sudden/Gradual, Low/High Grade 
 
2. Fever    Continuous/remittent/intermittent 
     Associated with Chills & Rigors 
     Diurnal Variation 
                                                    Night sweats 
3Headache: 
       Continuous /Paroxysmal 
     Mild/ Moderate/ Severe 
                 Localization of Pain 
                Aggravating Factors 
            Relieving Factors 
            Diurnal Variation 
              A/W Visual Disturbances/ Vomiting 
 
4. Altered Sensorium: 
 Mental Confusion 
        Altered consciousness  
Delirium 
 
 
5. Convulsions: 
Frequency 
Generalised /Focal 
Tongue Bite 
Sphincter control 
Loss of consciousness 
6. Vomiting: 
Numbs of times 
Quantity 
Nature 
Projectile 
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7. Paralysis Weakness: 
Monoplegia 
Hemiplegia 
Paraplegia 
Quadriplegia 
 
8. Speech: 
Loss of Speech 
Dysarthria 
9 Cranial Nerves: 
Loss of smell 
Defective Vision 
Diplopia 
Squint 
Difficulty in mastication 
Deviation of angle of month 
Vertigo 
Tinnitus 
Deafness 
Nasal Regurgitation 
Dysphagia 
Choking 
10. Loss of Appetite.& Loss of Weight 
11. Diabetes 
 
12.      Hypertension 
 
Past history 
Tuberculosis                     
Pulmonary/Pleural 
Lymphadenitis 
Tuberculosis of GIT 
Tuberculosis of Bones& Joints 
Family history  tuberculosis  
 
Personal history: 
1. Smoking  
2. Alcoholism 
3. Diet 
4. Marital status 
5. Number of Children 
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PHYSICAL EXAMINATION 
1.  Built 
2.  Nourishment 
3.  Anaemia 
4.  Jaundice 
5.  Cyanosis 
6.  Clubbing 
7.   Significant lymphadenopathy  
8.   Stigmata of tuberculosis 
9.   Vital signs:              
           Pulse rate 
 BP 
  RR 
 Temperature 
 
CNS EXAMINATION 
 
Higher functions: 
1.  Level consciousness 
2.  Appearance & Behaviour 
3. Hallucinations and delusions 
4. Orientation to time, place, person 
5. Memory & Intelligence 
6. Speech 
 
Examination n of cranial nerves: 
1. Olfactory: Anosmia/ Parosmia 
2.  Optic: Visual Acuity 
   Field of vision 
                    Vision 
   Fundus 
 
3. Oculomotor ptosis  
   Pupils 
4. Trochlear retraction of eyelids 
5. Abduscent: 
Squint 
Extra ocular Movement  
6 Trigeminal Motor  Sensory Motor 
    Reflexes 
    (Corneal/ Conjunctival/ Jaw) 
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7 Facial: 
 Elevation of Eyebrows 
    Frowning 
    Closure of Eyes 
    Nasolabial Fold 
    Deviation of .Angle of Mouth 
Whistling 
     Taste on anterior 2/3
rd
of tongue 
 
8.  Vestibulo-cochlear 
Acuity of hearing 
Rinne's test 
Weber's test 
9.  Glossopharvngeal:soft palate 
10.Vagus:   (Position, Movement, Reflex) 
Pharyngeal wall movement, Gag Reflex 
 
11. Spinal Accessory:      Sternomastoid Action 
    Trapezius Action 
 
12.  Hypoglossal   Tongue: wasting, fasciculation’s,  
movements of Tongue 
 
Motor System 
                                             Upper  limb                       Lower limb 
                                  Right           left                   Right           left  
 
Nutrition 
Tone 
Power 
Coordination 
Abnormal Movements 
 
Sensory System 
1 Superficial: Touch, Pain, and Temperature 
2 Deep: Joint, Position Vibration 
3 Cortical: Tactile Localisation. 
     Tactile Discrimination 
       Stereognosis 
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Reflexes                                            Right                  Left 
Superficial 
Corneal 
Conjuctival 
Abdominal 
Cremastric 
Plantar 
Deep 
Biceps 
Triceps 
Supinator 
Knee 
Ankle 
 
Signs of Meningeal irritation 
Neck Rigidity 
Kernig's Sign 
Brudzinki’s sign 
Cerebellar Functions 
Spine and cranium 
Gait 
Romberg’s Sign 
Peripheral Nerves 
 
 
INVESTIGATIONS 
 
1. Blood: 
Hb% 
TC, DC, ESR 
Urea, Creatinine 
Sugar 
2. Chest X-Ray 
3. Fundus 
4.       CSF: 
Gross Appearance 
Biochemical analysis 
(protein/glucose/chloride) 
Cell counting and study 
Microbiological study (grams 
stain/AFB/culture and sensitivity) 
5. CSF Cortisol     Pre treatment 
 Post treatment 
6.   Blood culture:   
7.   CT Brain/MRI brain: 
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LIST OF ABBREVIATIONS USED 
ACTH………................Adrenocorticotropic Hormone 
AFB ................ ……….Acid Fast Bacilli 
ADH…………………Anti-Diuretic Hormone 
ADA…………………Adenosine Deaminase 
AIDS .............. ………Acquired immunodeficiency syndrome 
ARP…………………Argyll-Robertson pupils 
BCG ............... ………Bacille Calmette Guerin 
CNS ................ ……...Central Nervous System 
CSF ................ ………Cerebrospinal fluid 
DOTS………..............Directly Observed Treatment, Short course 
EBV ............... ……..Epstein barr virus 
FTA ................ ……..Fluorescence treponemal antibody 
FISH..........................Fluorescence In Situ Hybridization 
HAART……............Highly Active Antiretroviral Therapy 
HIV ................ .........Human immunodeficiency virus 
HPA………………Hypothalamic-Pituitary Axis 
HSV ............... …....Herpes Simplex virus 
IV………………...Intra venous 
LDH ............... ……Lactate dehydrogenase 
MDR……………..Multi Drug Resistant 
MRC ............... …..Medical Research Council 
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PCR ................ ….Polymerase chain reaction 
RIA ................. …Radio Immuno Assay 
SD .................. …Standard deviation 
TBM ............... ...Tuberculous Meningitis 
VZV ............... ...Varicella Zoster virus 
VDRL............. ...Venereal disease research laboratory 
ZN Stain .......... ..Zeil Nelson stain 
ICU .................. .Intensive Care Unit 
WBC ............... .White Blood cells 
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KEY TO MASTER CHART 
 
 
AFB……………………Acid fast bacilli 
RBS……………………Random blood sugar 
C/S…………………….. Culture& Sensitivity 
CSF…………………….. Cerebrospinal fluid 
 
Coding: 
(+)…………… present 
(-)…………... absent 
 
Altered sensorium    
  1+……………Drowsy 
  2+……………Irritable 
  3+……………Stupor 
 
Seizures 
  1+…………… One episode 
  2+…………… Two episodes 
  3+……………Three episodes 
  6+…………… Six episodes 
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MASTER CHART 
 
sl 
no NAME AGE SEX FEVER 
VOM 
ITTING 
HEAD 
ACHE 
ALTE 
RED 
SEIZ 
URES 
MENIN 
GEAL focal  CELLS 
NEUTR 
OPHILS 
LYMPH 
OCYTES 
PRO 
TIEN 
SU 
GAR RBS CSF  
 post 
Rx 
GR 
AMS  AFB C/S of HIV  
diag 
nosis 
        
IN 
DAYS     
SENS 
ORIUM   SIGNS 
de 
ficits 
CO 
UNT % %       
cor 
tisol 
cort 
isol STAIN   CSF 
STA 
TUS   
1 pavithra 19 F 4 + + 3+ 2+ + + 200 90 10 112 34 140 15.2 1.9 positve - 
s.pneu 
moniae - 
Neutr 
ophilic 
2 mallika 45 F 3 + + - - + - 130 80 20 80 60 150 14.5 1.4 - - - - 
Neutr 
ophilic 
3 balakrishna 23 M 2 - + 1+ - + - 120 90 10 90 43 134 12.6 1 - - - - 
Neutro 
philic 
4 dhanalakshmi 46 F 3 + + - - + - 140 90 10 98 45 124 11.9 1 - - - - 
Neutro 
philic 
5 veera kumar 20 M 2 - + - - + - 160 85 15 110 48 160 13.4 1.3 - - - - 
Neutro 
philic 
6 babu 46 M 4 + + + - + - 90 95 5 80 69 110 10.3 1.1 - - - - 
Neutr 
ophilic 
7 shalini 18 F 3 + + - 2 + + - 30 10 90 30 77 96 2.4 0.9 - - - - Aseptic 
8 sumathi 17 F 3 + - 2+ - + + 150 20 80 90 43 105 4.6 1.2 - - - - 
lymp 
hocytic 
9 dhanalakshmi 56 F 4 + + + 1+ + - 230 10 90 114 30 112 5.2 1.5 - - - - 
lymph 
ocytic 
10 subramani 64 M 5 - + + - + - 20 15 85 35 80 125 2.3 1.2 - - - + Aseptic 
11 malar 40 F 4 + - - 1+ + - 300 20 80 130 26 124 5 0.9 - - - - 
lymph 
ocytic 
12 valliammal 70 F 5 + + 1+ - + - 50 10 90 70 58 94 3.1 1.4 - - - - Aseptic 
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13 shalini 54 F 4 + - 1+ - + - 180 5 95 120 54 90 4.3 1.6 - - - + 
lym 
phocytic 
14 surya 24 M 3 + + - 2+ + - 230 90 10 140 30 130 14.4 0.7 - - 
n.men 
ingitidis - 
Neut 
rophilic 
15 nias 20 m 4 + + 2+ 3+ + - 400 80 20 160 26 144 16.8 1.1 + - 
H influ 
enza - 
Neut 
rophilic 
16 murugan 45 M 2 + - 1+ - + - 210 10 90 140 38 136 5.3 1.8 - - - - 
lymp 
hocytic 
17 balachandran 33 M 5 + + - - + - 190 
                      
― 100 130 29 98 5.4 1.3 - - - - 
lymp 
hocytic 
18 acina 17 F 4 - + 1+ 1+ + - 340 90 10 135 34 102 15.3 1 + - 
s.pneu 
moniae - 
Neut 
rophilic 
19 gunamoorthy 40 M 3 + - - 2+ + - 220 85 15 114 40 154 13.8 0.8 - - - - 
Neut 
rophilic 
20 chandran 46 M 5 - + - - + - 280 90 10 155 32 135 12.9 1.3 + - 
s.pne 
umoniae - 
Neutro 
philic 
21 hariharan 17 M 3 + + 2+ 1+ + - 30 
                      
― 100 30 78 124 2.1 1.2 - - - - Aseptic 
22 senthil kumar 29 m 4 - - 1+ - + + 200 10 90 135 50 200 3.9 0.9 - - - - 
lympho 
cytic 
23 ravi 23 M 3 + - - - + - 45 
                      
― 100 45 82 180 2.5 1 - - - - Aseptic 
24 sundaran 17 m 2 + + 1+ - + - 85 5 95 160 86 176 3.8 1.7 - - - - 
lymp 
hocytic 
25 durga 21 F 2 + + 1+ 2+ + - 160 80 20 105 40 202 11.2 1.4 - - - - 
Neutr 
ophilic 
26 duraisamy 32 M 5 - + - - + - 180 90 10 100 36 184 12 1.3 - - - - 
Neut 
rophilic 
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27 arun kumar 26 m 4 + - - - + - 150 10 90 95 45 190 4.2 1.2 - - - + 
lymp 
hocytic 
28 logeshwari 17 F 2 + + - - + - 170 30 70 130 39 134 4 1.1 - - - - 
lymp 
hocytic 
29 somu 22 M 3 - + 2+ - + - 200 95 5 140 30 94 14.7 1.7 - - 
s.pneu 
moniae - 
Ne 
utrophilic 
30 raghu 18 m 3 + + 1+ - + - 140 2 98 110 46 178 4.6 1.9 - - - - 
lymp 
hocytic 
31 ponnusamy 29 M 4 + + - - + - 120 75 25 105 49 165 3.6 0.8 - - - - 
Neutr 
ophilic 
32 sasi 35 M 4 - - 1+ 1+ + + 230 15 85 125 48 204 4.5 0.9 - - - - 
lymph 
ocytic 
33 govindasamy 65 M 5 + + - 2+ + - 300 95 5 150 27 175 15.3 1 + - 
s.pneum 
oniae - 
Neut 
ophilic 
34 selvaraj 39 M 4 - - - - + - 35 
                      
― 100 35 66 96 2.4 1 - - - - Aseptic 
35 
uma 
maheswari 33 F 5 + + 1+ - + - 120 10 90 90 36 102 4.7 1.3 - - - - 
lymp 
hocytic 
36 kumarsamy 17 M 3 - + 1+ - + - 300 95 5 165 37 90 14 1 - - 
n.men 
ingitidis - 
Neutr 
ophilic 
37 jeyakodi 20 F 2 + - - - + - 170 5 95 125 33 135 3.3 0.8 - - - - 
lymp 
hocytic 
38 gunasekaran 16 M 2 + + - - + + 20 
                      
― 100 30 77 115 2 1.2 - - - - Aseptic 
39 keerthi vasan 17 M 3 + - 3+ 6+ + - 200 10 90 105 39 146 4.8 1.1 - - - - 
lymp 
hocytic 
40 baburan 40 M 4 + - - 1+ + - 180 20 80 114 43 112 3.2 0.9 - - - - 
lymp 
hocytic 
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xg;g[jy;  ; [ ;; [ ;; [ ; gotk;;;; 
 
bgah; : 
ghypdk; :      taJ : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; bghJ kUj;Jt 
Jiwapy; gl;lnkw]gog]g[ gapYk; khztd] mth;fs; nkw;bfhs;Sk;  
"jz]Ltl jputj]jpy] fhh]o!hy] Qhh]nkhd] mst[ bfhz]L 
ghf]Ohpahtpdhy] tUk] \isf]fha]r]riya[k]/ ghf]Ohpah my]yhj 
fpUkpapdhy] tUk] \isf]fha]r]riya[k] ntWgLj]Jjy] Fwpj]j 
Ma]t[" Fwpj;j Ma;tpy; bra;Kiw kw;Wk; midj;J 
tptu';fisa[k; nfl;Lf; bfhz;L vdJ re;njf';fis 
bjspt[g;gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 ehd; ,e;j Ma;tpy; KG rk;kjj;Jld;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tpgu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; 
btspaplg;gLtjpy; Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; 
bfhs;fpnwd;. ve;j neuj;jpYk] ,e;j Ma;tpypUe;J ehd; tpyfpf; 
bfhs;s vdf;F chpik cz;L vd;gija[k; mwpntd;. 
 
 
,lk;  :      ifbahg;gk; / nuif 
ehs; : 
 
 
